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Abstract 
Endonucleases appear to be key players in mammalian mRNA degradation, but 
the enzymes responsible are largely unknown. A novel mammalian endoribonuclease 
from rat liver that could cleave c-myc coding region determinant (CRD) RNA in vitro has 
been purified, and MALDI-MS data indicated that a candidate protein was Syntaxin 18. 
The objective of this thesis was to determine the endonucleolytic domain of Stxl8 
whereby truncated mutant forms of Stxl8 would be generated, purified, refolded, and 
tested for endonucleolytic activity. 
Unfortunately, new evidence came to light that questioned if Syntaxin 18 does in 
fact possess endoribonucleolytic activity, and thus the objective of this thesis shifted 
somewhat towards definitive determination of whether or not Syntaxin 18 is an 
endoribonuclease. Evidence presented herein strongly suggests that it is a small, as-yet 
unidentified co-purified protein, and not Syntaxin 18, that is responsible for the 
endonucleolytic activity seen. 
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Chapter 1 
Introduction 
Regulation of mRNA decay is a major control point in gene expression. The 
processes and key players of mRNA decay in bacteria and yeast are relatively well 
established and characterized. In contrast, there are major gaps in our understanding of 
mRNA decay machineries in mammalian cells. Endonucleases appear to be key players 
in mammalian mRNA degradation, but the enzymes responsible are largely unknown 
(Tourriere et al. 2002). This is partly due to the fact that mRNA cleavage products are 
highly unstable and therefore difficult to detect (Tourriere et al. 2002). A ~35 kDa liver 
endonuclease that cleaves c-myc coding region determinant (CRD) mRNA (nts 1705-
1792) was purified and tentatively identified as Syntaxin 18 (Bergstrom et al. 2006). 
Syntaxin 18 belongs to the soluble N-ethylmaleimide sensitive factor (NSF) attachment 
protein (SNAP) receptor (SNARE) family of vesicle trafficking proteins. The objective 
of this Master's thesis was to confirm the endonucleolytic activity of Syntaxin 18, and 
then to determine its catalytic domain by deletion mapping. 
As this project deals with a potential endoribonuclease, this introduction will 
review post-transcriptional regulation of gene expression, paying particular attention to 
mRNA decay. As Syntaxin 18 was tentatively identified as an endoribonuclease during 
studies involving the c-myc proto-oncogene, and c-myc coding region determinant (CRD) 
RNA was used as the RNA substrate during this investigation, a brief summary of the c-
myc gene will be discussed. Furthermore, the previously known biochemistry of 
Syntaxin 18 itself will be reviewed. Finally, a brief outline of the research objectives will 
be presented. 
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1.1 Post-Transcriptional Regulation in Prokaryotes 
mRNA has been recognized as the most unstable nucleic acid in the cell when 
compared to its counterparts, DNA, tRNA, and rRNA (Jain 2002). This instability, 
observed as the relative half-life of mRNA molecules, is intrinsic to the finding that 
control of mRNA half-lives can have great consequences on overall gene expression in 
the cell. Controlling gene expression at this level, by modifying mRNA half-lives, allows 
growing cells to quickly and efficiently adapt to changing environments (Jain 2002; 
Takayama et al. 2000). 
Studies of mRNA degradation in bacterial systems, namely Escherichia coli (E. 
coli), have led to a fundamental understanding of mRNA regulation that can be used to 
identify the differences and similarities of analogous processes in other organisms, 
including eukaryotes. A brief summary of how this organism controls mRNA turnover 
follows. 
In E. coli, mRNA turnover processes are carried out by a set of over a dozen 
ribonucleases (Jain 2002), some with more important roles than others. By far the most 
common pathway involves endonucleolytic cleavage by RNase E, and will be discussed 
in the most detail here. However, if mRNA molecules contain certain elements, such as 
specific secondary structures and RNase susceptibility sequences, they can be degraded 
independent of the RNase E cleavage event (Jain 2002). Due to this fact, individual E. 
coli mRNAs exhibit a large range of half-lives in vivo, from merely seconds to over an 
hour (Jain 2002). 
As stated above, typically E. coli mRNA degradation begins with the 
endonucleolytic cleavage of the transcript by RNase E, which renders the transcript 
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inactive for the purpose of translation (Halbeisen et al. 2007; Jain 2002). This cleavage 
event is followed by 3'-to-5' exonucleolytic decay through a number of ribonucleases, 
including some contained in a protein complex called the degradosome, which consists of 
RNase E, enolase, an RNA helicase (RhlB), and a 3'-to-5' exoribonuclease (PNPase) 
(Condon 2007; Nicholson 1999). Interestingly, E. coli does not have any 5'-to-3' 
exoribonucleases, but it has at least 7 more 3'-to-5' exoribonucleases in addition to 
PNPase (Zuo et al. 2001), including RNase II and RNase R (Condon 2007; Jain 2002). 
Under normal circumstances, the 3' ends of E. coli mRNAs are protected from 
exonucleolytic degradation from these enzymes by specific secondary structures, 
particularly the stem-loop of the Rho-independent transcription terminator (Condon 
2007). It is for this reason that the endonucleolytic cleavage of transcripts by RNase E is 
so essential to mRNA turnover in E. coli; these cleavage events create new, unprotected 
3' ends that the exoribonucleases can attack (Condon 2007). 
The exoribonucleases PNPase and RNase II efficiently degrade mRNA fragments 
into mononucleotides until the mRNA fragment gets too small (less than 10 nucleotides 
in length). At this point, both exoribonucleases dissociate from the mRNA fragment, 
leaving the oligonucleotides behind undigested. In E. coli, the enzyme responsible for 
degrading these oligonucleotides into mononucleotides is oligoribonuclease (Orn) (Jain 
2002; Nicholson 1999). This enzyme is so important to completing the process of 
mRNA turnover in E. coli that it is one of only three ribonucleases that are essential for 
viability, along with RNase E and RNase P (an enzyme involved in tRNA maturation) 
(Jain 2002). This protein completes the degradation process, leaving mononucleotides 
that are then available to be reused in nucleic acid synthesis. 
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1.2 Post-Transcriptional Regulation in Eukaryotes 
The regulation of gene expression within a eukaryotic organism has various 
points of control, including transcription, pre-messenger RNA (pre-mRNA) processing, 
mature mRNA transport from the nucleus to the cytoplasm, subcellular localization, 
translation efficiency, and mRNA degradation (Guhaniyogi et al. 2001; Tourriere et al. 
2002). The level of this regulation is of major importance for proteins that are only 
active for short periods of time like growth factors, transcription factors, and proteins that 
regulate cell cycle progression (Mitchell et al. 2000; Tourriere et al. 2002; Wilusz et al. 
2004). Over the years, many studies have determined that the regulation of mRNA is one 
of the more important control points in gene expression (Beelman et al. 1995; Decker et 
al. 2002; LaGrandeur et al. 1998). Steady-state levels of mRNA within a cell depend 
upon the combined rates of synthesis and processing, transport from the nucleus, and 
stability in the cytoplasm (Guhaniyogi et al. 2001; Tourriere et al. 2002). 
The regulation of mRNA stability is attained in a cell through variations in their 
half-lives. These half-lives change in response to developmental and environmental 
stimuli such as nutrient levels, cytokines, hormones, and temperature shifts, as well as 
environmental stresses including hypocalcaemia, hypoxia, viral infection and injury 
(Guhaniyogi et al. 2001; Tourriere et al. 2002; Zekri et al. 2005). The importance of the 
stability of mRNA molecules is inherent in the fact that stable mRNAs, with half-lives 
that can reach over 24 hours, permit an extended time of translation for genes to be 
expressed at high levels, whereas mRNAs that encode proteins that are produced only in 
bursts have relatively short half-lives, ranging from a few hours to just a few minutes 
(Guhaniyogi et al. 2001; Tourriere et al. 2002; Zekri et al. 2005). 
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The stability of an mRNA can be affected by specific interactions between its 
structure (known as cis-acting elements) and RNA-binding proteins (known as trans-
acting elements) (Guhaniyogi et al. 2001; Tourriere et al. 2002). Trans-acting elements 
are highly abundant, but examples of cw-acting elements include the 5'-cap, AU-rich 
elements (AREs, Barreau et al. 2005) in the 3'-UTR, and the 3'-poly(A) tail of mRNA 
molecules (Guhaniyogi et al. 2001). The 5'-cap and 3'-poly(A) tail structures of an 
mRNA are thought to act together to stimulate translation initiation, but the 5'-cap is also 
an important determinant of the stability of all mRNA molecules because it makes the 
body of the transcript resistant to exonucleolytic degradation from the 5' end (Couttet et 
al. 1997; Mitchell et al. 2000; Tourriere et al. 2002). The poly(A) tail has a similar 
secondary function on the 3' end. 
Research has indicated that there are two major categories, with somewhat 
differing subpathways, which are responsible for mRNA degradation in eukaryotes: a 
deadenylation-dependant group, in which the poly(A) tail must be shortened prior to 
mRNA degradation, and a deadenylation-independent group (Beelman et al 1995) 
(Figure 1). 
One deadenylation-dependant pathway in particular stands out from the rest as it 
has been extensively researched in yeast. This pathway is initiated by poly(A) tail 
shortening followed by decapping and 5'-3' exonucleolytic degradation of the transcript 
body (Dunckley et al. 1999; Schwartz et al. 2000; Tourriere et al. 2002). Another 
deadenylation-dependant pathway involves 3'-5' degradation by a protein complex called 
the exosome (Mitchell et al. 2000; Tourriere et al. 2002). 
5 
DEADENYLATIGN-DEPENDANT DECAY 
m
7G|AUG UAA |AAA+ 
POLVlAI SHORTENING 
mrG|AUG UAA I 
V to 5' DECAY 
.1EXOSOME) 
n'G 
UAA | nTG|AUG 
S" t o 3 - DECAY 
a 
€> 
DEADENYLATION-INDEPENDANT DECAY 
nTG|AUG UAA ~|flAA+ 
EMUOIIUCLEOLYTIC 
CLEAVAGE 
|AUG |BflA} UAA |AAA+
 m
7G|AUG UAA j Q A A A + 
5 -to} -DECAY 
(Xinlp) 
f <3 IjJAAl UAA |AAA+ 
3'to 5-DECAY 5 - to 3'DECAY 
Figure 1: mRNA decay pathways in eukaryotes (adapted from Beelman et al. 1995). 
A schematic diagram outlining the two general pathways by which mRNA is degraded 
within eukaryotic cells. Pacman symbols represent nucleases. 
In the deadenylation-independent category, there are also two general pathways. 
The first is termed the nonsense-mediated decay (NMD) pathway and is involved in 
mRNA surveillance, which is the process by which aberrant mRNAs are rapidly 
decapped and degraded without prior poly(A) shortening (Beelman et al. 1995; Parker et 
al. 2004). The other deadenylation-independent mRNA decay pathway involves 
endoribonucleolytic cleavage of the mRNA within its body, followed by exonucleolytic 
decay of the resulting 5' and 3' fragments (Beelman et al. 1995; Parker et al. 2004). 
It is important to note that many different mRNAs can be degraded by a single 
degradation pathway and that a single mRNA can also be degraded by multiple, 
seemingly redundant decay pathways, lending evidence to the fact that mRNA 
degradation is a complex and highly regulated process which must be further studied in 
order to fully determine the significance of its role in the regulation of gene expression. 
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1.2.1 Deadenylation-Dependant Decay 
Most eukaryotic mRNAs are polyadenylated, and the 3'-poly(A) tail plays an 
important role in transport of the mRNA from the nucleus to the cytoplasm, translation 
initiation, and protection of the mRNA from exonucleolytic decay (Guhaniyogi et al. 
2001). Within the cytoplasm, most poly(A) tails are bound by a poly(A) binding protein 
(PABP in mammals, Pablp in yeast) which protects the mRNA from 3'-5' exonucleases 
and deadenylases (Meyer et al. 2004; Tourriere et al. 2002). Studies have shown that 
PABP bound to the poly(A) tail interacts with the translation initiation factor eIF4F 
which binds to the 5'-cap during translation initiation (Mitchell et al. 2000; Tourriere et 
al. 2002; Vilela et al. 2000). In a process not fully understood, but thought to be due to 
transient binding of the PABP to the poly(A) tail, polyadenylase enzymes can degrade the 
poly(A) tail when PABP is not bound (Mitchell et al. 2000). As deadenylation proceeds, 
PABP binding sites are removed, and once there are no PABP binding sites left an 
inhibition to decapping of the mRNA is relieved. How PABP inhibits decapping is not 
yet fully understood, but this effect is believed to occur somehow in relation to PABP's 
ability to bind eIF4F (Caponigro et al. 1995; Couttet et al 1997; Tourriere et al. 2002). 
This hypothesis has been recently supported by exciting mRNA turnover research 
in mouse NIH3T3 fibroblasts (Yamashita et al. 2005). The results from this work 
suggest that mammalian mRNA deadenylation is a biphasic process, the likes of which 
has not been observed in any other organisms to date. In simple terms, two enzyme 
complexes were found to be required for proper mRNA deadenylation: the PAN2-PAN3 
complex and the CCR4-CAF1 complex (Yamashita et al. 2005). The PAN2-PAN3 
complex initiates deadenylation and proceeds degrading the poly(A) tail until ~110 
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nucleotides of the tail is left, after which the complex dissociates from the mRNA 
molecule and the CCR4-CAF1 complex takes over the job (Yamashita et al. 2005). 
These facts were deduced from the observation that PAN2-deleted fibroblasts 
accumulated mRNAs with full-length poly(A) tails, whereas CCR4-deleted fibroblasts 
accumulated mRNAs with -110 nucleotide-long poly(A) tails (Yamashita et al. 2005). It 
has been hypothesized that this effect occurs due to intrinsic properties of PABP; it has 
been found that the PAN2-PAN3 complex may be recruited to the poly(A) tail by the 
many PABP molecules bound to the full-length transcript (Uchida et al. 2004). Once the 
PAN2-PAN3 complex has digested the poly(A) tail to the length of ~110 nucleotides, it 
is thought that there is no longer a sufficient amount of bound PABP to recruit PAN2-
PAN3, and this is why the PAN2-PAN3 complex dissociates (Yamashita et al. 2005). At 
this point in time, there is also insufficient PABP bound to the poly(A) tail to effectively 
inhibit the CCR4-CAF1 complex, and thus this complex takes over and continues 
digesting the poly(A) tail (Yamashita et al. 2005). A schematic model of these 
interesting findings is presented in Figure 2. 
It is possible that not having PABP bound to the poly(A) tail because there is no 
tail left could facilitate the release of the cap-binding component of eIF4F, thereby 
subjecting the mRNA to decapping since the 5'-cap structure is exposed (Mitchell et al. 
2000; Tourriere et al. 2002). Consistent with this speculation is the finding that deletion 
of Pablp in yeast confers lethality due to widespread defects in translation initiation and 
mRNA stability (Tourriere et al. 2002). 
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Figure 2: Enzyme complexes associated with biphasic mRNA deadenylation in 
mouse NIH3T3 fibroblasts. In the first phase, the CCR4-CAF1 exonuclease complex is 
initially inhibited by many PABP molecules bound to the poly(A) tail; however, these 
same PABP proteins recruit the PAN2-PAN3 complex to digest the poly(A) tail. Once 
the poly(A) tail reaches a length of ~110 nucleotides, there is insufficient PABP bound to 
the remaining poly(A) tail to recruit PAN2-PAN3, and thus the CCR4-CAF1 complex is 
free to digest the remainder of the poly(A) tail in the second phase (from Yamashita et al. 
2005). 
Research has indicated that many mRNAs, including mammalian c-fos mRNA, do 
not decay until their poly(A) tails are shortened, and this shortening appears to be carried 
out by different poly(A) specific ribonucleases in yeast (PAN) (Meyer et al. 2004) and 
mammals (PARN) (Parker et al. 2004; Wilusz et al. 2004). PARN was purified from 
HeLa cells (a human cervical cancer cell line) and its deadenylation ability is stimulated 
by presence of the 5'-cap (Mitchell et al. 2000). PARN homologs have been found in 
other mammals, but interestingly there appears to be no homolog in yeast (Tourriere et al. 
2002). PAN is not essential in yeast as PARN is in mammals, and PAN deleted strains of 
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yeast had no significant reduction of deadenylase activity, suggesting that important yeast 
deadenylases have yet to be discovered (Meyer et al. 2004; Tourriere et al. 2002). 
Once deadenylation has taken place, the next major step in the degradation of 
yeast mRNAs is decapping (LaGrandeur et al. 1998; Mitchell et al. 2000). It has been 
noted that different mRNAs are decapped at different rates, and thus decapping has been 
recognized as a control point in the regulation of decay (Dunckley et al. 1999). The rate 
of decapping is affected by several factors, not the least of which is the remaining length 
of the shortened poly (A) tail (Tourriere et al. 2002). 
In yeast, the removal of the methylated guanosine (m -G) cap structure is 
executed by two proteins named Dcplp and Dcp2p (Lehner et al. 2004; Parker et al. 
2004; Wilusz et al. 2004). Dcplp is the actual catalytic enzyme, but Dcp2p is required 
for Dcplp's activity by an unknown mechanism (Dunckley et al. 1999; Tourriere et al. 
2002). It has been suggested that Dcp2p activates Dcplp in some way through chemical 
modification. This suggestion came about with the discovery that Dcplp purified to 
homogeneity from wild-type yeast strains has decapping activity, whereas it does not 
when purified to homogeneity from Dcp2pA strains (Dunckley et al. 1999; LaGrandeur et 
al. 1998). 
There is indirect evidence that decapping follows deadenylation in mammals as 
described above for yeast, at least for some mRNAs. Such evidences include the finding 
of deadenylated, decapped full-length mRNAs in murine liver cells, and the finding in 
plants and animals of mRNA decay intermediates that are shortened at their 5'-ends 
(Guhaniyogi et al. 2001; Schwartz et al. 2000). Further work must be carried out to 
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determine the degradation pathways following deadenylation and decapping in mammals 
(Couttet et al. 1997; Guhaniyogi et al. 2001). 
In yeast, degradation of the mRNA body by 5'-3' and 3'-5' exonucleolytic 
degradation follows deadenylation and decapping (Guhaniyogi et al. 2001; Tourriere et 
al. 2002). The primary enzyme responsible for this degradation in yeast is Xrnlp, which 
degrades the transcript body in a 5'-3' exonucleolytic fashion (Hsu et al. 1993; 
Mukherjee et al. 2002; Parker et al. 2004). Xrnlp is highly conserved in eukaryotes and 
the mammalian homolog is fully functional in yeast (Tourriere et al. 2002). The 
degradation of mRNA constitutes the final step in mRNA turnover (Decker et al. 2002; 
Tourriere et al. 2002). 
Mutations in yeast that block decapping, and therefore 5'-3' degradation by 
Xrnlp, led to the discovery of a 3'-5' degradation pathway. This degradation pathway 
involves a complex of proteins called the exosome (Lehner et al. 2004; Mitchell et al. 
1997; Parker et al. 2004). The exosome of yeast is comprised of at least five essential 
proteins: Rrp4p, Rrp41p, Rrp42p, Rrp43p and Rrp44p (Mitchell et al. 1997). 
Interestingly, the first four proteins are homologous to the bacterial 3'-5' exoribonuclease 
RNasePH, while Rrp44p is homologous to RNasell (Mitchell et al. 1997). Exosome 
components are highly conserved throughout eukarya, and several human exosome 
proteins have been identified (Decker et al. 2002; Tourriere et al. 2002). 
When discovered, the exosome was thought to have only nuclear functions 
including the processing and degradation of small nuclear RNAs (snRNAs), small 
nucleolar RNAs (snoRNAs) and rRNAs. Since this time it has been found that the 
exosome also functions in the cytoplasm where it is responsible for a general 3'-5' 
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degradation pathway of deadenylated mRNAs (Mitchell et al. 1997; Tourriere et al. 
2002). Indeed, relatively recent research has demonstrated that in mammalian cell 
extracts it is actually this 3'-5' degradation pathway mediated by the exosome that 
predominates the mammalian mRNA decay process, rather than the 5'-3' decay process 
of yeast (Brewer 1999; Mukherjee et al. 2002; Wang et al. 2001). This conclusion was 
supported by experiments showing that mRNA degradation fragments shortened from the 
3' end are much more abundant in cell extracts than decay fragments shortened from the 
5' end (Brewer 1999; Mukherjee et al. 2002; Wang et al. 2001). 
1.2.2 Deadenylation-Independent Decay 
As described above, most mRNAs have their poly(A) tails slowly shortened 
before the rapid degradation of the transcript body. mRNA half-lives can be significantly 
reduced, however, by a specialized pathway that triggers the decapping of the mRNA 
molecule before deadenylation (Mitchell et al. 2000). This pathway, called the nonsense-
mediated decay (NMD) pathway, targets aberrant mRNAs as part of a highly conserved 
cellular process called mRNA surveillance (Culbertson 1999; Guhaniyogi et al. 2001; 
Wagner et al. 2002). The NMD pathway prevents the accumulation of truncated proteins 
which could be deleterious to the cell by ensuring rapid degradation of the irregular 
mRNAs (Culbertson 1999; Guhaniyogi et al. 2001; Wagner et al. 2002). Molecules that 
are degraded by this pathway include mRNAs that contain premature termination codons 
(PTCs), unspliced introns and extended 3'-UTRs (Guhaniyogi et al. 2001; Wagner et al. 
2002). 
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1.2.2.1 Nonsense-mediated mRNA decay in yeast 
In yeast, the NMD pathway involves deadenylation-independent 
decapping of the mRNA molecule by Dcplp/Dcp2p followed by 5'-3' exonucleolytic 
degradation by Xrnlp (Guhaniyogi et al. 2001; Wagner et al. 2002) and 3'-5' 
exonucleolytic degradation by the exosome (Conti et al. 2005; Mitchell et al. 2003). This 
process is identical to the regular mode of mRNA degradation in yeast except that the 
transcript has not been slowly deadenylated. This means that there is some process that 
can recognize abnormalities within the mRNA and trigger decapping and degradation. In 
yeast, two models have recently been proposed for how such recognition occurs in the 
NMD of aberrant transcripts specifically containing premature termination codons 
(PTCs). The first takes into consideration the finding that many yeast mRNAs contain 
poorly defined downstream sequence elements (DSEs) that are required for NMD to 
occur if they are found 3' of a termination codon (Baker et al. 2004; Conti et al. 2005). 
These DSEs have furthermore been found to be bound by a protein named Hrplp, which 
has in turn been found to interact with one of the core proteins of the NMD pathway, 
Upf lp (Conti et al. 2005). It has been suggested that this interaction may serve to recruit 
other protein components of the NMD pathway to the mRNA molecule, but further 
research must be done to confirm this hypothesis (Baker et al. 2004; Conti et al. 2005). 
The second model suggests that the trigger for NMD of PTC-containing 
transcripts is simply a generic feature of the mRNA transcript itself, such as the poly(A) 
tail bound by Pablp (Conti et al 2005). In this model, it is recognized that the poly(A) 
tail (and therefore Pablp) is in close proximity to normal translation termination codons 
in yeast, and it therefore may be the distance of a PTC from the poly(A) tail that initiates 
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the NMD pathway (Baker et al 2004; Conti et al. 2005). It is believed that this process 
would be come to pass due to the failure of a ribosome stalled at a PTC to properly 
interact with Pablp (Baker et al. 2004). How this event might recruit the NMD pathway 
proteins to the mRNA transcript is not yet understood, but evidence supporting this 
model has come to light; it has been observed that translation termination is abnormal at 
PTCs and prematurely terminating ribosomes fail to release the mRNA efficiently, and 
this effect is abolished in yeast strains lacking Upf lp (Conti et al. 2005). 
Regardless of how an mRNA transcript is recognized as being aberrant, the core 
NMD-associated proteins that have been found to be conserved across eukaryotes are 
Upflp, Upf2p and Upfip (Culbertson 1999; Wagner et al. 2002). The exact mechanisms 
by which these proteins trigger the actual decay process of NMD is not yet known, but it 
is thought that the specific activity may lie within Upf2p and/or Upf3p, as purified Upflp 
has been shown to have very unspecific RNA and DNA helicase activities (Beelman et 
al. 1995; Culbertson 1999). 
1.2.2.2 Nonsense-mediated mRNA decay in mammals 
NMD in mammals has been found to be a much more complex process 
than in yeast. The Upf 1, Upf2, and Upf3 proteins are conserved and are therefore still the 
core NMD factors, but their mode of action appears different in mammals than in yeast as 
mammalian NMD is dependant on pre-mRNA splicing (Lejeune et al. 2005). In 
mammals, a large protein complex is deposited on spliced mRNA molecules at exon-
exon junctions in the nucleus, and this complex is called the exon junction complex 
(EJC) (Holbrook et al. 2004; Lejeune et al. 2005). The EJC is typically deposited -20-24 
nucleotides upstream of every exon-exon junction in the transcript (Holbrook et al. 
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2004). The EJC is comprised of many proteins, including the NMD core factors Upf2 
and Upf3: other proteins associate include RNPS1, UAP56, SRml60, and Pun/DRS 
(proteins associated with pre-mRNA splicing), REF/Aly, Y14, and Magoh (proteins 
involved in mRNA export), and eIF4AIII, Barentz/MLN51, and PYM (proteins with as-
yet unknown functions) (Holbrook et al. 2004; Lejeune et al. 2005). 
EJCs are proposed to mediate mammalian NMD simply by their location within 
the transcript; in normal mRNAs the last EJC will always be upstream of the translation 
termination codon, whereas in aberrant PTC-containing transcripts an EJC may end up 
downstream of the PTC. Indeed, this appears to be a key situation in mammalian NMD 
as evidenced by the observation that mRNAs from intronless genes (and therefore lacking 
exon-exon junctions and EJCs), such as those for histone H4, heat shock protein 70, and 
melanocortin 4-receptor, are immune to NMD (Lejeune et al. 2005). 
The mechanism by which EJCs are thought to mediate NMD is complicated. 
First, it must be noted that EJCs are only detected on mRNAs bound by the cap binding 
complex (CBP) 80/20 proteins; most mRNAs undergoing bulk translation are bound by 
eIF4E rather than this complex (Chang et al. 2007; Lejeune et al. 2005). This and other 
findings suggest that mRNA probably undergoes a pioneer round of translation by a 
ribosome, and it is during this round that mRNA is determined as being aberrant or not 
(Chang et al. 2007). The current model is thus: a pioneering ribosome begins translating 
the CBP 80/20-bound transcript and, if the transcript is normal, the ribosome easily 
dislodges all EJCs from the mRNA body as it reads the transcript. Once the ribosome 
reaches the proper termination codon, the CBP 80/20 complex dissociates from the 5'-
cap and eIF4E binds to the cap, and the mRNA is now ready to undergo bulk translation 
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(Chang et al. 2007; Lejeune et al. 2005). If, however, the ribosome encounters a PTC 
while reading the transcript, it pauses and a downstream EJC (containing Upf2 and Upf3) 
is thought to recruit Upf 1 to the transcript and in this way the transcript is targeted for 
NMD degradation (Lejeune et al. 2005). 
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Figure 3: Mechanisms of PTC determination and decay of PTC-containing 
transcripts in yeast and mammals, (a) PTCs are detected in yeast either via a protein, 
Hrplp, binding to a downstream sequence element (DSE) or via lack of interaction 
between the stalled ribosome and the poly(A) tail binding protein (Pablp). In mammals, 
PTCs are thought to be determined by the presence of an exon-exon junction complex 
(EJC) downstream from the PTC. (b) Once PTCs are recognized, the mechanism by 
which aberrant mRNAs are degraded appears to be conserved between yeast and 
mammals (adapted from Conti et al. 2005). 
Other experiments demonstrated that there are exceptions to the NMD processes 
explained here, and that some mRNAs that don't even contain PTCs are still targeted for 
NMD degradation, shows that this cellular process of mRNA surveillance is still in the 
early stages of characterization in both yeast and mammals, and much further research 
must be carried out in order to elucidate all the pathways and factors involved. 
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Once the transcript has been identified as aberrant, independent of poly(A) tail 
shortening, the transcript is rapidly degraded by the same familiar factors already 
described for yeast; the mRNA is decapped by the DCP1 and DCP2 proteins, and the 
transcript body is degraded exonucleolytically 5'-to-3' by XRN1 and 3'-to-5' by the 
exosome (Conti et al. 2005). A schematic diagram depicting the basic NMD approach of 
both yeast and mammals is shown in Figure 3. 
1.2.2.3 Endoribonucleolytic Decay 
Strictly speaking, the NMD pathway described above is not a part of the 
regulation of normal mRNA levels, as its purpose is to degrade abnormal transcripts. 
This would lead one to believe that deadenylation-dependant pathways are the only 
processes by which levels of normal mRNAs are regulated were it not for the presence of 
endoribonucleases. Endoribonucleases cleave an mRNA molecule somewhere within its 
body, generating a 5'-fragment and a 3'-fragment (Guhaniyogi et al. 2001; Parker et al. 
2004). These fragments are then exposed to 3'-5' and 5'-3' degradation, respectively 
(Guhaniyogi et al. 2001). Despite experiments demonstrating that endonucleases are 
significant effectors of mRNA degradation, the enzymes responsible are still largely 
unknown (Tourriere et al. 2002). The reason for this lack of information is due to the 
inherent instability of endonuclease cleavage fragments, which makes the detection of 
mRNA decay intermediates very difficult (Hanson et al. 2001; Tourriere et al. 2002). 
To date, a number of mRNAs have been found to be cleaved endonucleolytically. Such 
mRNAs include the cytokine groa (Stoeckle 1992; Zekri et al. 2005), avian apo-very low 
density lipoprotein (Binder et al. 1989; Zekri et al. 2005), albumin (Brown et al. 1993; 
Chernokalskaya et al. 1997), maternal homeodomain proteins (Brown et al. 1990), 
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vitellogenin (Cunningham et ah 2000), insulin-like growth factor II (IGF2) (Meinsma et 
ah 1991; Nielsen et ah 1992), transferrin receptor (TfR) (Binder et ah 1994), c-myc 
(Ioannidis et ah 1996; Lee et ah 1998), and a-globin (Wang et ah 2000; Wang et ah 
2000). Much work must be carried out in order to fully understand the mechanisms and 
enzymes involved in the cleavage of these mRNA substrates, but so far some interesting 
information has come to light. It has been discovered that many endoribonuclease 
activities are constitutively active and therefore the accessibility to the mRNA cleavage 
sites by the enzymes must be strictly regulated (Guhaniyogi et ah 2001) (Figure 4). 
Figure 4: Hypothetical endonucleolytic mRNA decay schematic (from Tourriere et 
al. 2002) 
Furthermore, higher order structures of the target mRNA molecules themselves have 
been determined to play key roles in either masking a cleavage site through binding of 
trans-acting decay regulator proteins, or by targeting the endonuclease to the cleavage 
site (Rodgers et ah 2002; Tourriere et ah 2002). 
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The identification and characterization of endoribonucleases and the mRNAs they 
cleave is important to our full comprehension of the complex process of eukaryotic 
mRNA degradation. The fact that endoribonucleases can cleave substrate mRNA 
independent of the rate-limiting step of deadenylation speaks for their emerging 
importance in the regulation of the stability of specific mRNAs. To date, there have been 
approximately 9 vertebrate endoribonuclease proteins identified; these proteins include 
ARD-1, PMR1, ErEn, IRE1, G3BP, RNase L, Dicer, and Argonaute2. A brief review of 
each of these endoribonucleases follows. 
ARD-1 (activator of RNA decay) was a human cDNA sequence that was found to 
reverse the pleiotropic effects of temperature-sensitive and deletion mutations of the 
RNase E gene in E. coli (Claverie-Martin et al. 1997). Analysis of the cDNA indicated 
that it encoded a 13.3 kDa protein that appeared to share multiple structural elements 
with the 118 kDa RNase E protein (Claverie-Martin et al. 1997). Experiments in which 
the ARD-1-encoding protein was overexpressed in E. coli and purified by affinity-
column chromatography demonstrated that the ARD-1 protein is indeed a single-strand-
specific Mg2+-dependant endoribonuclease (Claverie-Martin et al. 1997). ARD-1 protein 
was also shown to bind to and cleave RNase E substrates at the same sites, and leaving 
the same 5'-phosphate termini on the cleavage fragments, as RNase E (Claverie-Martin et 
al. 1997). Since the protein was discovered in the manner described above, it was 
unclear whether or not it actually existed as a discrete protein in human cells; Chang et 
al. found that it actually does exist in human cells, and furthermore it appears to be the 
result of an alternative splicing event of the NIPP-1 gene, which encodes an inhibitor of 
protein phosphatase-1 (Chang et al. 1999). From the information gained to date, it 
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appears that ARD-1 is a human functional analog of the E. coli RNase E protein, but the 
implications of this discovery on mammalian mRNA turnover processes has yet to be 
determined. 
PMR1 (polysomal ribonuclease 1) was identified as an estrogen-induced 
endonucleolytic activity that appeared on polysomes coincident with the activation of 
mRNA decay in Xenopus liver (Cunningham et al. 2001). The protein responsible was 
determined to have a molecular weight of ~63 kDa and has no similar sequence motifs to 
known endonucleases; in actuality, PMR1 has been determined to be a member of the 
peroxidase gene family (Cunningham et al. 2001; Yang et al. 2004). PMR1 has been 
shown to preferentially cleave single-stranded RNA at an AYUGA element within the 5'-
coding region of albumin mRNA (Hanson et al. 2001). It has also been demonstrated to 
cleave vitellogenin mRNA, and due to its ubiquitous expression in Xenopus tissues it has 
been proposed that PMR1 is a key enzyme in an estrogen-induced global mRNA decay 
pathway (Cunningham et al. 2001). 
ErEn (erythroid-enriched endoribonuclease) is an endoribonuclease that has been 
demonstrated to specifically cleave a-globin mRNA within the 3'-UTR (Liu et al. 2007). 
This cleavage is very specific and has been mapped to nucleotides 63-64 (CU) 
downstream of the translation stop codon (Liu et al. 2007). In contrast to other 
characterized endoribonucleases such as Argonaute2 and PMR1, ErEn cleavage of 
mRNA yields a 3'-phosphate and 5'-hydroxyl on the cleavage fragments; this mode of 
hydrolysis closely resembles the RNase A family of endoribonucleases, but interestingly 
ErEn is resistant to the RNase A inhibitor, RNasin (Liu et al. 2007). It is believed that 
the physiological role of ErEn is in maintaining coordinated levels of a-globin and (3-
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globin mRNAs by ensuring that a-globin mRNA levels do not exceed P-globin mRNA 
levels (Liu et al. 2007). This is critical because free a-globin monomers in the absence of 
P-globin monomers will aggregate and precipitate onto the cell membrane, which leads to 
inefficient erythropoiesis and peripheral hemolysis (Liu et al. 2007). 
IRE1 (inositol-requiring enzyme 1) is an ER transmembrane protein 
kinase/endoribonuclease with a molecular weight of 110 kDa (Tirasophon et al. 2000; 
Zhang et al. 2005). IRE1 is involved in the unfolded protein response (UPR) pathway of 
eukaryotic cells; its N-terminus lies within the ER lumen (where unfolded and misfolded 
proteins accumulate under ER stress conditions) while the C-terminus lies within the 
cytoplasm and contains the protein kinase and endoribonuclease domains (Tirasophon et 
al. 2000). Upon accumulation of unfolded or misfolded proteins, IRE1 activates via an 
unknown mechanism and initiates the unconventional splicing of the mRNA encoding 
the transcription factor X-box-binding protein (XBP1) (Zhang et al. 2005). IRE1 mutants 
were used to map the endonucleolytic activity of the protein to nucleotides 196, 644, 672, 
and 673 (corresponding to GC, UG, AC, and CU dinucleotides, respectively) (Tirasophon 
et al. 2000). The splicing event on XBP1 mRNA removes a 26-nucleotide intron, 
generating a switch in the translational reading frame; the newly spliced mRNA then 
encodes a strong transcriptional activator that induces the expression of target UPR genes 
(Zhang et al. 2005). 
The RasGAP SH3 domain binding protein (G3BP) is a 52 kDa protein that 
associates with Ras GTPase-activating protein pi20 (RasGAP) (Zekri et al. 2005). This 
protein specifically cleaves between a CA dinucleotides in a single-stranded portion of 
the AU-rich element in the 3'-UTR of c-myc mRNA (Zekri et al. 2005). The G3BP 
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sequence contains an N-terminal domain homologous to nuclear transporter factor 2 
(NTF2) and a C-terminal RNA recognition module (RRM) (Zekri et al. 2005). Besides 
being demonstrated as an endoribonuclease in vitro, G3BP has also been implicated as a 
DNA/RNA helicase III, a regulator of ubiquitin protease activity, and a transcription 
cofactor during vaccinia virus late replication (Zekri et al. 2005). The exact 
physiological role of G3BP is not yet known, but recent findings using mice suggest that 
G3BP integrates activating and silencing signals to control fetal growth and viability at 
birth (Zekri et al. 2005). 
2'-5' oligoadenylate-dependant ribonuclease L (RNase L) is an 84 kDa protein 
that is one of the key enzymes involved in the function of interferons, a family of 
cytokines that participate in innate cellular immunity to viral and other microbial 
pathogens (Liang et al. 2006). RNase L activity was characterized due to its importance 
in the interferon-induced 2-5A system (Liang et al. 2006). In this system, 2-5A 
synthetase enzymes require double-stranded RNA (dsRNA), which is frequently 
produced during viral infections, for their activity (Liang et al. 2006). Once activated, 
these synthetases convert ATP to pyrophosphatase and a series of unique 5'-
phosphorylated, 2'-5' linked oligoadenylates (2-5As) which bind to inactive RNase L 
monomers and convert them into their highly active, homodimeric form (Liang et al. 
2006). This RNase L homodimer then proceeds to degrade single-stranded viral and 
ribosomal RNAs, usually at UA and UU dinucleotides, and in this way aids the body in a 
fight against viral infection (Liang et al. 2006; Mishra 2002). 
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The final two characterized vertebrate endoribonucleases are Dicer and 
Argonaute2; both proteins are involved in RNA interference (RNAi), a process by which 
specific gene silencing is brought on by the cellular presence of double-stranded RNA 
(Hammond et al. 2001). Dicer is a -200 kDa protein that is responsible for processing 
dsRNA into -20 nucleotide-long small interfering RNAs (siRNAs) (Zhang et al. 2004). 
The resultant siRNA molecules then join the RNA-induced silencing complex (RISC), of 
which Argonaute2, a -130 kDa protein, is a component (Liu et a/.2004). The siRNA 
recruited to the RISC acts as a guide sequence such that the Argonaute2 protein can 
endonucleolytically cleave any mRNA that has full sequence complementarity to the 
siRNA; in this way, genes can be silenced due to the incurred instability to their mRNA 
transcripts (Liu et al. 2004). A summary of the vertebrate endoribonucleases described 
above is shown in Table 1. 
1.3 The c-myc proto-oncogene 
C-myc mRNA is one of the well studied mammalian mRNAs and it has been 
shown to be degraded endonucleolytically. A specific coding region of c-myc called 
coding region determinant (CRD) has been shown to be cleaved internally and has been 
used to purify the responsible endoribonuclease. This section of the thesis aims to 
provide some background on c-myc and its relevance to this thesis. 
1.3.1 c-myc structure and function 
Myc genes were first discovered as the transforming genes (v-myc) of a group of 
acute avian leukemia retroviruses (Brugge et al. 1991; Ryan et al. 1996). Homolog 
studies subsequently found a human cellular equivalent (c-myc) gene, mapped on human 
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chromosome 8q24 (Cylene Pharmaceuticals 2005). C-myc has been determined to be a 
3-exon transcription unit, in which Exon 1 is non-coding and Exons 2 and 3 code for the 
Myc proteins (Boxer et al. 2001; Brugge et al. 1991). The oncogene codes for several 
polypeptides, including a 62 kDa protein (c-myc 2) produced from a canonical AUG 
translational start site and a 64 kDa protein (c-myc 1) produced from an upstream CUG 
codon (Boxer et al. 2001). Furthermore, an internal translational initiation can result in a 
shortened 45 kDa version of the protein, named myc-S (Boxer et al. 2001). All three 
forms are active as they share certain conserved domains in their N- and C-terminal 
regions, as well as a nuclear localization signal found near the center of the gene (Ryan et 
al. 1996). 
Many experiments and studies have been performed over the years, elucidating 
myc's function in cells. Such functions include affecting cellular proliferation, apoptosis, 
and metabolism in a positive manner, while affecting cellular differentiation and adhesion 
in a negative manner (Boxer et al. 2001; Schmidt 1999). Further support of these 
conclusions comes from the relatively recent discoveries of specific genes that are 
activated by Myc complexes, and such genes are involved in amino acid/protein 
synthesis, nucleotide/DNA synthesis, ribosome biosynthesis, protein turnover/folding, 
lipid metabolism, transport, signal transduction, transcription/splicing, and translation 
(Boxer et al. 2001; Lutz et al. 2002). 
1.3.2 c-myc''s role in cancer and regulation of c-myc expression 
For a tumour cell to develop, more than one mutation must accumulate in a single 
cell, and the deregulation of c-myc activity and levels of its mRNA appears to be a 
common theme of tumourigenesis (Boxer et al. 2001; Lutz et al. 2002). C-myc's role in 
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cancer comes about through the processes of c-myc's induction of transformation, 
immortalization, and blockage of cellular differentiation when it is deregulated in cells 
(Cole et al. 1999). This deregulation has been demonstrated to originate from the 
conversion of the c-myc proto-oncogene to its oncogenic variant through proviral 
insertion, chromosomal translocation, gene amplification, and mutations that increase the 
transcription rate or alter the stability of the c-myc mRNA (Ryan et al. 1996). These 
mechanisms that deregulate c-myc expression occur in many types of tumour cells, as can 
be seen in Table 2. 
Table 2: Incidence of c-myc overexpression in primary tumours (Cylene 
Pharmaceuticals 2005) 
Primary Tumour Incidence of c-myc overexpression 
Breast 33-70% 
Cervical 77-100% 
Colorectal 70-87% 
Leukemia Most, if not all hematogenic malignancies 
Lymphoma Most; well characterized in Burkitt's Lymphoma 
Lung (NSCLC) 45% 
Lung (SCLC) 100% of poorest prognosis variant 
Ovarian 40% 
Pancreatic 31-44% 
Prostate 90% 
One well-documented example of c-myc deregulation in cancer is the case of 
Burkitt's lymphomas. In approximately 80% of Burkitt's lymphomas there is a 
chromosomal translocation present that involves the immunoglobulin heavy-chain locus 
on chromosome 14 and the c-myc oncogene on chromosome 8 (Boxer et al. 2001; 
Tannock et al. 1998). In the remaining 20% of Burkitt's lymphomas, there is a 
translocation between the c-myc oncogene and immunoglobulin light-chain loci on 
chromosomes 2 or 22 (Boxer et al. 2001; Tannock et al. 1998). The result of these 
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chromosomal translocations is that the c-myc oncogene comes under the influence of the 
strong immunoglobulin enhancer sequences, and as such c-myc becomes overexpressed 
(Tannock et al. 1998). 
Due to c-myc's prevalence in human cancers, and the mode by which it aids 
cancer development, it is imperative that studies be performed in order to determine just 
how c-myc expression is regulated within the cell. Indeed, many studies over the world 
have been conducted with goal of understanding this process. One such study discovered 
that the c-myc oncogene is affected by four promoters; one upstream of the gene, two in 
Exon 1, and one in Exon 2 of the gene (Boxer et al. 2001). Furthermore, several 
transcription factors have been reported to interact with regions of the gene in order to 
control expression of the gene (Boxer et al. 2001). However, these factors control c-myc 
expression only at the transcriptional level, and it is also possible to control expression of 
the gene at the translational, post-translational and, more related to this research, the post-
transcriptional level (Facchini et al. 1998; Ryan et al. 1996). C-myc mRNA can also be 
regulated at the post-transcriptional level through mRNA stability modification by 
mRNA degrading enzymes (Brewer 1998; Lee et al. 1998) and this is discussed in the 
following section. 
1.3.3 Discovery of endonucleases that cleave c-myc mRNA in vitro 
It has been previously shown that c-myc mRNA can be nucleolytically degraded 
in a 3'- untranslated region (UTR)-dependant fashion following deadenylation (Brewer 
1998). This thesis was more concerned with the endonucleolytic cleavage of c-myc 
mRNA by a polysomal endoribonuclease (Lee et al. 1998). 
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This tentative endoribonuclease is a -39 kDa protein that attacks the coding 
region determinant (CRD) of c-myc mRNA (Lee et al. 1998). The CRD is made up of 
the last 180-250 nucleotides of the coding region and has also been shown to be a binding 
site for a protein thought to shield the mRNA from endonucleolytic cleavage (Lee et al. 
1998). Cleavage of c-myc mRNA by this endoribonuclease occurs in the 5'-half of the 
CRD, termed the 5'-CRD RNA, as can be seen in Figure 5. 
A PCR-based method identified the cleavage site of this nuclease as being 5'-
CAAUGAAAAG-3' and although the exact cleavage specifics were not elucidated it was 
concluded that it prefers to cleave in an A-rich region (Lee et al. 1998). The 
5-UTR 
Coding Region 
^ ^ 
3'-UTR 
c-myc mRNA 
Full Length (FL)-CRD of c-myc mRNA 
5-CRD of c-myc mRNA 
CRD 
Figure 5: Human c-myc mRNA schematic (from Lee et al. 1998). The internal 
structure of c-myc mRNA, showing CRD, UTRs, FL-CRD, and 5'-CRD. 
endonuclease is a magnesium-dependent protein appeared to be resistant to RNase A 
inhibitors (thus it is not a member of the RNase A family), is completely inactivated by 
proteinase K treatment, and cleaves mRNAs other than c-myc mRNA (Lee et al. 1998). 
These findings are important as they move us closer to identifying true mammalian 
RNases and further our understanding of mRNA regulation. 
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In an effort to re-purify and identify this endonuclease that a second, smaller 
polysome-associated enzyme possibly capable of cleaving c-myc mRNA in the CRD was 
discovered (Bergstrom et al. 2006). At the outset of this thesis, the -35 kDa protein was 
tentatively identified as syntaxin 18 and it appeared to be capable of degrading single-
and double-stranded RNA. 
1.4 SNARE proteins and Syntaxin 18 
One of the primary objectives of this investigation was to confirm the tentatively 
identified endonucleolytic activity of the human syntaxin 18 protein. Syntaxin 18 is a 
soluble N-ethylmaleimide sensitive factor (NSF) attachment protein (SNAP) receptor 
(SNARE) and is involved in vesicle trafficking, specifically being an endoplasmic 
reticulum (ER)-membrane associated protein. This section will briefly describe the 
structure and function of SNARE proteins and their involvement in vesicle trafficking 
processes. Also, what is known of the structure and function of syntaxin 18 will be 
reviewed. 
1.4.1 SNARE proteins and vesicle trafficking 
Eukaryotic cells, by their very nature, are highly compartmentalized, with many 
membrane-bound organelles and similar structures within a single cell. As such, 
trafficking of specific proteins and compounds between organelles and into the cytoplasm 
is an extremely important process, allowing the cell to keep certain biochemical reactions 
segregated from one another. Such intracellular transport of compounds between 
membrane-bound compartments is mediated by vesicles. 
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The docking and fusion of these vesicles to their target membrane require the 
combined action of two proteins found in the cytosol: NSF and a-SNAP (Teng et al. 
2001). Recombinant NSF and a-SNAP were used in an affinity purification procedure 
based on the natural binding of these proteins to other proteins, and it was in this way that 
the first SNAP receptors, SNAREs, were found (Sollner et al. 2003). 
The first SNAREs to be studied in any detail were the synaptic proteins syntaxin 1 
(Stxl), SNAP-25, and vesicle-associated membrane protein (VAMP), also known as 
synaptobrevin (Chen et al. 2001). Stxl and VAMP are both membrane-anchored 
proteins, owing to their C-terminal transmembrane domains; SNAP-25, on the other 
hand, is attached to membrane surfaces by palmitoylation (Chen et al. 2001). 
In the past, SNARE proteins were classified as either v-SNAREs (vesicle-
associated SNAREs) or t-SNAREs (target-SNAREs), based on the assumption that V-
SNAREs had partner t-SNAREs for the purpose of specific targeting of vesicles to their 
destination membranes. Today, however, SNAREs have been reclassified into two 
groups based on a conserved residue located in a key region of SNARE proteins; the two 
groups are R-SNAREs (arginine-containing SNAREs, the old v-SNAREs) and Q-
SNARES (glutamine-containing SNAREs, the old t-SNAREs). A review of the 
mechanisms by which these proteins interact and facilitate membrane fusion is indicative 
of a general mechanism used by all SNAREs. 
All SNARE proteins share conserved heptad repeat sequences in their membrane-
proximal regions that can form coiled-coil secondary structures (Chen et al. 2001). 
These regions allow SNARE proteins to form a-helical coiled-coil complexes with each 
other that are very strong, being SDS-resistant, protease digestion resistant, and heat 
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stable up to ~90°C (Armstrong 2000; Chen et al. 2001); one estimate also puts the half-
life of spontaneous disassembly of these complexes at 1010 years (Sorensen 2005). It is 
these associations that are thought to drive membrane fusion by an action that is ATP-
independent (Chen et al. 2001). 
The currently accepted model of membrane fusion facilitated by SNAREs 
revolves around the four-stranded coiled-coil complex formed by a syntaxin (donating 
one coil), a VAMP-family member (donating one coil), and a SNAP (donating 2 coils) 
(Chen et al. 2001). It is believed that when a vesicle approaches a target membrane, the 
VAMP-family member, being an R-SNARE, comes into contact with and begins 
associating with the Q-SNARE SNAP protein (Chen et al. 2001). At this point in time, 
the association is reversible; however, soon a Ca2+ ion signal triggers the irreversible 
assembly of the rest of the SNARE complex, with the syntaxin joining in and completing 
the formation of the 4-stranded coiled-coil (Chen et al. 2001). A 'zipping' action has 
been hypothesized by which the strands tightly associate starting at their cytosol-exposed 
N-terminal ends and work their way down to their C-terminal anchors; this progressive 
zipping up of a very energetically favourable complex provides the energy required to 
drive the two membranes in close enough proximity to one another to force fusion (Chen 
et al. 2001). Figure 6 shows a schematic diagram of this SNARE-mediated membrane 
fusion process, as well as a representation of the 4-stranded a-helical coiled-coil SNARE 
complex. 
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Figure 6: SNARE proteins form a 4-stranded complex that drives membrane fusion 
(adapted from Chen et al. 2001). (a) An approaching vesicle associates with a SNAP 
protein (shown in green) on the target-membrane surface via a VAMP protein (shown in 
blue) on the vesicle surface. A Ca2+ signal triggers the irreversible association of the 
entire complex, including a syntaxin protein (shown in red), driving the membranes into 
such close proximity that fusion of the membranes takes place, (b) Structure of the 4-
stranded coiled-coil SNARE complex; colours of strands represent the same proteins as 
shown in (a). 
Once the membranes are fused, the coiled-coil SNARE complex needs to be 
disassembled. It is this disassembly process where the combined action of the two 
required cytosolic proteins, NSF and a-SNAP, finally play their role. a-SNAP helps to 
recruit NSF to the coiled-coil complex by its own association with the complex; once 
NSF is recruited it hydrolyses an ATP molecule and a conformational change in the NSF 
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protein forces the complex to dissociate (Chen et al. 2001). Once dissociated, the 
SNAREs involved are free to participate in future rounds of vesicle trafficking. 
1.4.2 Syntaxin 18, an ER-associated Q-SNARE 
Syntaxin 18 (Stxl8) is a Q-SNARE that was discovered by using a-SNAP as bait 
in a yeast two-hybrid system experiment (Hatsuzawa et al. 2000). The protein is 
comprised of 335 amino acid residues and has a calculated molecular weight of 38,673 
Daltons (Hatsuzawa et al. 2000). Like most syntaxins, Stxl8 has a C-terminal 
transmembrane domain and a coiled-coil SNARE motif (Hatsuzawa et al. 2000). A 
tertiary structure of Stxl8 was predicted by the Robetta Full-Chain Protein Structure 
Prediction Server using the crystal structure of a neuronal Secl/Stxl A complex as a 
template (Kim et al. 2004). A representation of the predicted Stxl8 tertiary structure 
compared to this crystal structure determination of the neuronal Secl/Stxl A complex is 
shown in Figure 7. 
Of special interest concerning the structure of Stxl8 is the short length of its 
transmembrane domain; most plasma-membrane located SNAREs, including StxlA and 
Stx2, have transmembrane domains >23 amino acid residues in length (Okumura et al. 
2006). Stxl8 on the other hand, like Stx5, has a 17 amino acid residue long 
transmembrane domain, which is indicative of an ER-Golgi membrane associated 
SNARE (Hatsuzawa et al. 2000; Okumura et al. 2006). 
Biostatistical analysis of the Stxl8 sequence show that it is most similar to the 
yeast Ufelp protein, but this similarity is very small with just 11.9% identity and 22.7% 
similarity (Hatsuzawa et al. 2000). Ufelp is a Q-SNARE implicated in both retrograde 
ER-Golgi vesicle transport and homotypic ER membrane fusion (Hatsuzawa et al. 2000). 
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This analysis served as a base to start looking for how Stxl 8 may function in vivo, but 
owing to the low similarity the comparison between Stxl8 and Ufelp cannot be 
considered definitive evidence as to Stxl8s function in cells. 
In order to determine the subcellular localization of Stxl 8, and therefore provide 
evidence of Stxl8s role in cellular processes, membrane fractionation experiments were 
Figure 7: Robetta server ab initio generated tertiary structure of Stxl8. Using the 
crystal structure of the neuronal Secl/StxlA complex as a template, the Robetta server 
(Kim et al 2004) was used to tentatively determine the three-dimensional structure of 
Stxl 8. 
carried out. These experiments demonstrated that Stxl8 was enriched in smooth-ER 
fractions, and was also found to a lesser extent in rough-ER and Golgi membranes 
(Hatsuzawa et al. 2000). Being a SNARE protein, these results suggested that Stxl8 is 
most likely involved in the transport of proteins in the ER-Golgi trafficking system, just 
like Ufelp is in yeast (Hatsuzawa et al. 2000). 
34 
Two findings in particular support this hypothesized role of Stxl8. 
Overexpression of Stxl8 was found to cause aggregation of ER membranes (Hatsuzawa 
et al. 2000). More importantly, however, was the finding that overexpression of Stxl8 
also disrupted vesicle trafficking into and out of the ER, without causing any discernible 
changes in mitochondria, lysosomes, or peroxisomes (Bossis et al. 2006; Hatsuzawa et al. 
2000). It has been suggested that this aggregation of ER membranes caused by Stxl8 
overexpression may be due to Stxl8 molecules interacting with each other via their 
cytosolic domains; this suggestion was made due to Stxl8's similarity to Ufelp, which 
has been shown to form higher order multimers (Hatsuzawa et al. 2000). It is thought 
that this ability to interact with each other may have functional significance in the case of 
homotypic membrane fusion, of which Ufelp has been demonstrated to play a role in, but 
Stxl8 has not as of yet (Teng et al. 2001). 
Recently, Stxl8 has been postulated to play a role in ER-mediated phagocytosis 
(Hatsuzawa et al. 2006). This hypothesis was developed after the finding that Stxl8, as 
well as two other ER-localized SNARE proteins, D12 and Sec22b, were noticeably 
enriched in phagosomes purified from the murine macrophage-like cell line J774 
(Hatsuzawa et al. 2006). In order to elucidate possible functions of these proteins, 
siRNAs were used to induce knockdown of the proteins in the J774 cell line; knockdown 
of Stxl8 was found to inhibit Fc receptor-mediated phagocytosis (Hatsuzawa et al. 2006). 
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1.5 Research Objectives 
At the outset of this thesis, Stxl8 was identified as an endoribonuclease 
responsible for the endonucleolytic cleavage of c-myc CRD RNA in vitro (Urquhart 
2006). The tentative identification came about from MALDI-mass spectrometry analysis 
of the purified -35 kDa protein, as well as Western blot analysis of the purified -35 kDa 
protein with Stxl8-specific antibody (Urquhart 2006). The objective of this investigation 
was to characterize the catalytic domain of Stxl8 using His6-tagged recombinant 
truncated forms of the protein expressed in E. coli. This goal was to be met through the 
completion of two specific project aims. The first aim involved the determination of the 
endonucleolytic domain of Stx 18 by C-terminal deletion mapping, whereas the second 
aim sought to determine which amino acid residues within the endonucleolytic domain 
were responsible for catalytic activity by using the alanine-scanning approach. 
C-terminal deletion mapping of the Stx 18 catalytic domain involved the 
sequential deletion of segments of the C-terminal end of the polypeptide. It was 
hypothesized that the truncated proteins generated from these C-terminal deletions that 
still contained the endonucleolytic domain would still exhibit endonuclease activity in 
vitro. The easiest method to generate these truncated proteins involved modification of 
the DNA from which they were transcribed and then translated via a PCR-based 
approach: deleting segments from the 3'-end of the DNA molecule would result in C-
terminal deletions. Expression and purification of recombinant proteins would then be 
carried out using E. coli as a host, and the concluding step to Aim I would involve testing 
the purified recombinant proteins for endonuclease activity using the standard 
endonuclease assay on c-myc CRD RNA (nts 1705-1792) (Bergstrom et al, 2006). 
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Testing each protein using this assay would allow determination of the endonucleolytic 
domain of the full-length Stxl8 protein. 
Unfortunately, throughout the course of this work, the validity of the work that 
concluded that Stxl8 was indeed an endoribonuclease capable of degrading c-myc CRD 
RNA in vitro came into question. As such, the primary focus of this investigation was 
somewhat changed; the new purpose was to definitively determine if Stxl8 and its 
truncated variants (mutants) can in fact act as an endoribonuclease against c-myc CRD 
RNA in vitro using a His -tagged recombinant form of the protein expressed in E. coli. 
Determining whether or not Stxl8 has the ability to cleave mRNA, as suggested by the 
previous studies of Urquhart, is important as it may provide a functional link between 
mRNA decay mechanisms and vesicle transport processes. Of course, if Stxl8 is found 
to be able to cleave mRNA in vitro, new experiments will need to be derived to 
determine if Stxl8 has the same ability in vivo. 
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Chapter 2 
Generation and Purification of Wild-type and Truncated Mutant Forms 
of Syntaxin 18 
This chapter describes the experimental approach used to generate and purify the 
wild type recombinant syntaxin 18 and the C-terminal deletion mutant forms of the 
syntaxin 18 protein. A PCR-based approach was used to generate cDNA sequences 
corresponding to each of the recombinant proteins, and these were then ligated into 
expression vectors for the purpose of inducing the expression of the recombinant proteins 
in an E. coli system. Successfully expressed recombinant proteins were then purified 
from bacterial cell pellets under denaturing conditions using His -tag Ni-NTA affinity 
chromatography technology. Presence of target recombinant protein in purified 
recombinant protein samples was then confirmed via Western blot analysis before testing 
the proteins for endonuclease activity. Furthermore, this chapter covers the presentation 
and critical analysis of experimental results. 
2.1 Methodology 
2.1.1 PCR generation and preparation of truncated mutant syntaxin 18 
cDNA 
Generation of C-terminal deletion mutants of the Stxl8 protein involved first 
generating 5'-deletion mutant DNA inserts from which the mutant proteins would be 
derived. To this end, a PCR-based approach was used. One forward and four reverse 
primers were designed by a colleague, Joel Urquhart, and submitted to Invitrogen 
(Invitrogen Life Technologies, Toronto ON, Canada) for synthesis, and are described in 
Table 3. Lyophilized primers were resuspended in 200 uL deionized water and 
quantified using UV/Vis spectroscopy. To ensure that each primer used for PCR 
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reactions was the same concentration, these samples were used as stocks to make 
working samples with a concentration of 100 ng/uL each. 
Full-length syntaxin 18 cDNA (concentration 0.5 ug/uL) was obtained from 
OriGene Technologies Inc. (OriGene, Rockville MD, USA) and was used as the template 
for the PCR-based approach to generate Stxl8 truncated mutants. The PCR reaction 
mixture and cycle specifications are given in Table 4; to ensure maximum productivity, 
each PCR reaction was done in quintuplicate. 
Table 3: Primers used in the generation of 5'-deletion mutant Stxl8 DNA. F denotes 
forward primer and R# denotes reverse primers. Highlighted sequences denote restriction 
enzyme cleavage sites (Ndel in the forward primer, Sad in the reverse primers). 
Primer identity Primer sequence 
(F) HuStxl8FNdel 5'-CGA TAT ATC VIA TGG CGG TGG ACA TCA CGC TGC 
TAT-3' 
(Rl) JTM-RTX18 5'-CGA CGA (i( i rCT AGA AGC CAG CGT TGT TTT TAA 
T-3' 
(R2) NewJl-RTX18 5'-CGA CGA GCT CCT AGG CAG GGT TTT CTT CAG AGT 
C-3' 
(R3) NewJ3-RTXl 8 5'-CGA C( i A GCT CCT ATC GTT CTG TGT CTG TCA TCC 
T-3' 
(R4)NewJ5-RTX18 5'-CGACGA G( i C CT ACT TGG GCC GGG GGC TCC GGC 
G-3' 
Table 4: PCR reaction mixture and PCR cycle specifications used in the generation 
of Stxl8 truncated mutant cDNA 
Reagent Volume PCR sequence 
Stx 18 DNA template 1 uL Step 1: 94°C for 30 seconds 
lOxPCR buffer 3.5 uL Step 2: 50°C for 30 seconds 
2.5 raM dNTPs 3.5 uL Step 3: 72°C for 45 seconds 
Forward primer (100 ng/uL) 1 |JL Step 4: Repeat steps 1-3 for 30 cycles 
Reverse primer (100 ng/uL) 1 uL 
Taq polymerase 0.5 uL 
Deionized water 24.5 uL 
Total volume 35 uL 
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Once PCR was complete, -the five tubes of PCR reaction mixture for each 
truncated mutant cDNA was stored at -20°C until such time that they could be 
electrophoretically run on an agarose gel. 2 uL of DNA loading dye (0.25% 
bromophenol blue, 0.25% xylene cyanol, 15% ficoll) were added to each PCR tube and 
samples were loaded onto a 1% agarose gel and run for 1 hour at 42 mA. The gel was 
then visualized under UV light and the single bands corresponding to the PCR products 
were excised; gel slices containing product were placed in clean 1.5 mL Eppendorf tubes. 
PCR product was then purified from the agarose gel slices using a QIAEX II Gel 
Extraction Kit (Qiagen Inc., Valencia CA). 
First, 600 uL of Buffer QX1 was added to the Eppendorf tubes containing the gel 
slices. The QIAEX II particle suspension was then vortexed for 30 seconds and 20 uL of 
this suspension was added to the samples. Samples were incubated at 50°C for 10 
minutes, with vortexing every 2 minutes, to solubilize the agarose and allow the QIAEX 
II particles to bind to the DNA. After all agarose was dissolved, tubes were centrifuged 
at maximum speed for 30 seconds and the supernatant was removed and discarded. The 
pellets were washed with 500 uL of Buffer QX1 and the samples were resuspended by 
vortexing, followed by centrifugation at maximum speed for 30 seconds. The 
supernatants were removed and discarded. The pellets were then washed with 500 uL of 
Buffer PE and the samples were resuspended by vortexing followed by centrifugation at 
maximum speed for 30 seconds. The supernatants were removed and discarded, and 
another identical wash step with Buffer PE was performed. Following the second Buffer 
PE wash, the pellets were allowed to air-dry for 10-15 minutes. PCR product DNA was 
eluted from the QIAEX II particles by resuspending the pellets in 20 uL water, pH 8.0, 
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followed by incubation at room temperature for 5 minutes. Samples were then 
centrifuged at maximum speed for 30 seconds, and the supernatants containing the DNA 
were removed and placed in new, clean 1.5 mL Eppendorf tubes. An identical elution 
step was performed on each pellet once more resulting in a total final volume of 40 uL 
eluted DNA for each PCR reaction. 
To prepare the truncated mutant cDNAs for ligation into expression vectors, an 
ethanol precipitation followed by a restriction digestion of the cDNAs and the vectors 
themselves had to be performed. Eighty uL of each truncated mutant cDNA was 
collected and placed into clean 1.5 mL Eppendorf tubes. Eight uL of 3M sodium acetate, 
pH 5.2 and 200 uL 100% ethanol were added to the tubes and mixed thoroughly by 
agitation. DNA was precipitated by incubating the tubes at -20°C for 15 minutes. Tubes 
were centrifuged at 12,000 RPM in an Eppendorf 5415R centrifuge for 30 minutes and 
the supernatant was gently removed and discarded. The DNA pellet was carefully 
washed with 200 uL cold 70% ethanol in water and centrifuged at 12,000 RPM for 5 
minutes. The supernatant was again gently removed and discarded. The DNA pellet was 
allowed to air dry for 15 minutes at room temperature followed by resuspension of the 
pellet in 20 uL of deionized water. DNA concentrations were determined using an ND-
1000 UV/Vis Spectrophotometer (Nanodrop Technologies, Wilmington DE) and the 
concentrations for all four mutant cDNAs ranged from 0.27-0.40 ug/uL. 
2.1.2 Ligation of PCR-generated inserts into expression vector plasmids 
pHTT7K expression plasmid containing an insert of full-length wild-type 
syntaxin 18 was generously provided by Dr. Chow H. Lee; however, expression plasmids 
containing inserts for the truncated mutant forms of syntaxin 18 had to be generated via 
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ligation of the PCR-generated inserts. Expression vectors used in this investigation are 
shown in Figure 8; pHTT7K provided by Dr. Chow Lee was used initially, but for 
reasons explained later a switch to Novagen's pET28a was made. To ligate the purified 
PCR-generated inserts into expression vector plasmids, both the vector and the inserts 
first had to be digested with Ndel and Sad restriction enzymes. In each case, 1.5 ug of 
DNA was added to 1 uL each of Ndel and Sad, 2 uL of NEBuffer 4, 1 uL lOxBSA and 
an amount of deionized water bringing the total reaction volume to 20 uL. These 
reactions were carried out at 37°C for two hours, after which they were heat-deactivated 
by incubation at 65°C for 20 minutes. 
Two uL DNA loading dye was then added to each sample, and all samples were 
loaded onto a 1% agarose gel. The gel was run at 42 mA for 1 hour and the gel was 
visualized under UV light. Bands corresponding to DNA insert and/or linearized 
expression vector were then cut out and placed into clean 1.5 mL Eppendorf tubes. The 
DNA was extracted from the agarose gel slices using a QIAEX II Gel Extraction Kit 
(protocol described previously). DNA was then purified from the reactions by ethanol 
precipitation and quantified using an ND-1000 UV/Vis Spectrophotometer (Nanodrop). 
Concentrations of DNA given in |ig/uL were converted into femtomoles (fmols)/uL such 
that molar ratios between insert and plasmid DNA could be considered for the ligation 
reactions. Ligation reactions were carried out between each insert and expression vector 
at three different insert to vector ratios: 3:1, 4:1 and 5:1. Typically, a ligation mixture 
consisted of ~ 150 fmols of vector, 450/600/750 fmols of insert depending on the ratio 
desired, 1 uL ligase, 2 uL T4 ligase buffer and an amount of deionized water bringing the 
total reaction volume to 15 uL. These ligation reactions were incubated overnight at 
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Figure 8: Expression vectors used in the expression of 6xHis-tagged recombinant 
proteins. (A) The primary expression vector used throughout this work was 
pET28a/b(+). Syntaxin 18 full-length and truncated mutant cDNAs were subcloned into 
pET28a/b(+) downstream of an N-terminal 6xHis-tag. Plasmid and cDNAs were cut 
with Ndel and Sad restriction enzymes. (B) Initially, this work sought to express and 
purify recombinant proteins using the pHTT7K vector, but sub-optimal protein induction 
led to the eventual use of Novagen's pET28a/b(+) vector instead. 
43 
room temperature and used directly to transform electrocompetent Escherichia coli 
DH5a cells. 
2.1.3 Preparation of competent cells 
During this investigation, two different lines of competent cells were prepared. The first 
was an electrocompetent culture of is. coli DH5a cells, which are ideally suited for large 
scale expression and purification of plasmid DNA. The other was a heat-shock 
competent culture of E. coli BL21 cells, which are ideally suited for the overexpression 
of exogenous proteins. The methods by which these cultures of competent cells were 
prepared are outlined below. 
2.1.3.1 Preparation of electrocompetent E. coli DH5a cells 
Preparation of electrocompetent cells began by inoculating 3.0 mL of LB broth 
(Invitrogen) with a stab E. coli DH5a cells frozen at -80°C. This small culture was 
incubated overnight at 37°C with agitation. The following day 2.5 mL of this starter 
culture was used to inoculate 250 mL of LB broth, which was then incubated at 37°C 
with agitation until the optical density at 600nm reached a value between 0.5-0.7 (ODgoo 
= 0.5-0.7). The culture was then split into cold 40mL Nalgene tubes and centrifuged at 
5750 RPM in a Beckman Coulter Avanti HP-20 XPI centrifuge for 15 minutes at 4°C (all 
centrifugation steps were carried out using a Beckman Coulter Avanti HP-20 XPI 
centrifuge). The supernatant was discarded and the cell pellets dissolved in 10% 
glycerol, followed by centrifugation at 5750 RPM for 10 minutes at 4°C. The 
supernatant was again discarded and the pellets from all tubes were resuspended in 10% 
glycerol. All cell suspensions were combined and then centrifuged again at 5750 RPM 
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for 10 minutes at 4°C. This wash of the combined cell suspensions was performed an 
additional two times, and after the final centrifugation the cell pellet was dissolved in 1 
mL of 10% glycerol. This cell suspension was then dispensed into 1.5 mL Eppendorf 
tubes in 50 uL aliquots, and all tubes were frozen at -80°C. E. coli DH5a cells prepared 
in this way were viable for transformation for up to one month. 
2.1.3.2 Preparation of competent E. coli BL21 cells for use in 
transformation using heat-shock method 
Competent E. coli BL21 protein expression cells began with inoculating 
50 mL of LB broth with a stab of frozen E. coli BL21 stock. The cell suspension was 
incubated at 37°C with agitation until an ODgoo of 0.3-0.6 was reached. Cells were then 
centrifuged at 2500 RPM in a Beckman Coulter Avanti HP-20 XPI centrifuge for 5 
minutes at room temperature, and the cell pellet was carefully resuspended in 2.5 mL of 
50 mM calcium chloride (CaCh). Once resuspended, the cell suspension was brought up 
to a volume of 25 mL with further 50 mM CaCl2 and chilled on ice for 30 minutes. The 
suspension was again centrifuged at 2500 RPM for 5 minutes at room temperature and 
the cell pellet was resuspended in 5 mL 50 mM CaCl2. The suspension was then stored at 
4°C and was viable for transformation for up to 2 weeks. 
2.1.4 Transformation of E. coli competent cells 
As described previously, two different types of competent cells were prepared 
depending on whether they were to be used for plasmid expression and purification (E. 
coli DH5a cells) or protein expression and purification (E. coli BL21 cells). The 
following section describes the different methods by which these competent cells were 
transformed. 
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2.1.4.1 Electrotransformation of E. coli DH5a cells with ligation mixes 
In preparation for electrotransformation of E. coli DH5a cells with ligation 
mixes, all DNA samples, cell aliquots and cuvettes were retrieved from the freezer and 
kept cold on ice. For each transformation reaction, 5 uL of ligation mix was added to a 
50 uL aliquot of thawed electrocompetent DH5a cells. A Biorad Gene Pulser Xcell 
(Biorad Laboratories Inc., Hercules CA) was set to electroshock E. coli with a cuvette 
size of 0.2 cm, and cell/ligation mixes were pipetted into the bottom of a cold Gene 
Pulser Xcell cuvette. The cells were electroshocked and 1 mL of SOC medium was 
immediately added to the sample. Once all samples were treated thus, they were 
transferred to 50 mL tubes and incubated at 37°C for 1 hour with agitation. Ten uL, 100 
uL and 200 uL of the cell suspensions were then plated on LB-agar (Invitrogen) plates 
containing 25 ug/mL kanamycin sulphate (Invitrogen) and incubated at 37°C overnight. 
Control plates were also made by treating a sample without any ligation mix in the same 
manner as above. 
2.1.4.2 Transformation of E. coli BL21 cells using heat-shock method 
Transformation of E. coli BL21 cells with expression vector plasmids was 
carried out using a traditional heat-shock method. Approximately 200 ng of purified 
expression vector plasmid was added to 200 uL of competent E. coli BL21 cells, and the 
cells were iced for 30 minutes. The cell/plasmid suspension was then subjected to heat 
shock at 42°C for 2 minutes and again placed on ice. 1 mL of LB broth was added to the 
suspensions and they were then incubated at 37°C for 30 minutes with agitation. 1:10, 
1:100 and 1:200 dilutions of this suspension were then plated on LB-agar (Invitrogen) 
plates containing 25 ug/mL kanamycin sulphate (Invitrogen) and were incubated at 37°C 
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overnight. A single, isolated positive clone was then removed from the plate and used to 
inoculate 3 mL of LB broth containing 25 ug/mL kanamycin sulphate at 37°C with 
agitation overnight. 
2.1.5 Small-scale purification of plasmids and analysis for positive clones 
Success of transformation was determined by small-scale purification of plasmid 
from grown colonies and assessing them for positive clones via restriction digest 
analysis. Fifteen colonies from each insert/vector reaction (5 from 3:1,5 from 4:1 and 5 
from 5:1 insert to vector ratio ligation mixes) were plucked and placed in 15 mL round-
bottom tubes with 2 mL LB broth and 2 uL 25 mg/mL kanamycin. These cultures were 
incubated at 37°C overnight. After incubation, 1 mL of each culture was transferred to a 
1.5 mL Eppendorf tube and centrifuged at 13,200 RPM in an Eppendorf 5415R 
centrifuge for 2 minutes. Supernatant was removed and cell pellets were resuspended in 
500 uL STET buffer. Ten uL 50 mg/mL lysozyme was added and cultures were vortexed 
for ~1 minute to mix well. Samples were then boiled for 3 minutes and centrifuged at 
13,200 RPM for 10 minutes, after which the white, chromosomal DNA pellet was 
removed with a sterile toothpick. Five hundred uL isopropanol was added to induce 
plasmid DNA precipitation and the samples were placed in a -20°C freezer for at least 30 
minutes. After this time, samples were centrifuged at 13,200 RPM for 12 minutes and 
the supernatant was discarded. The crude plasmid DNA pellet was washed with 200 uL 
70% ethanol and centrifuged at 13,200 RPM for 5 minutes. The supernatant was again 
discarded and the pellet was allowed to air dry at room temperature for -30 minutes 
before being resuspended in 20 uL deionized water. 
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These crudely purified plasmid DNA samples were used for restriction digest 
analysis. Three uL of plasmid was added to 1 uL each of Ndel and Sad, 2 uL NEBuffer 
4, 1 uL lOxBSA and 3 uL of deionized water, bringing the total reaction volume to 10 
uL. Samples were incubated at 37°C for 45 minutes after which 1 uL of 10 mg/mL 
RNaseA and 1.5 uL of DNA dye was added. The entire samples were then run on a 1% 
agarose gel at a current of 45 milliamps (mA) for 1 hour. The gel was visualized under 
UV light and the presence of an insert band at the expected insert size indicated a positive 
clone that could be used for large-scale plasmid purification. 
2.1.6 Large-scale plasmid preparation of positive clones 
Leftover starter cultures of positive clones identified in the small-scale plasmid 
purification process were used to generate larger cultures for large-scale plasmid 
purification using a QIAGEN Plasmid Midi Kit (QIAGEN Inc.). One hundred uL of 
starter culture was used to inoculate 100 mL LB broth and 100 uL 25 mg/mL kanamycin. 
Cultures were incubated overnight (at least 12 hours) at 37°C with agitation. Bacterial 
cells were harvested by centrifugation at 7040 RPM in a Beckman Coulter Avanti HP-20 
XPI centrifuge for 15 minutes at 4°C. Bacterial cell pellets were resuspended in 4 mL 
Buffer PI, followed by addition of 4 mL Buffer P2. The samples were mixed by 
vigorous inversion 4-6 times and incubated at room temperature for 5 minutes. Four mL 
chilled Buffer P3 was then added and the samples were again mixed by vigourous 
inversion 4-6 times, followed by incubation on ice for 15 minutes. Cell lysates were then 
centrifuged at 12,860 RPM for 30 minutes at 4°C, and the supernatant containing the 
plasmid DNA was removed. Supernatant was centrifuged again at 12,860 RPM for 15 
minutes at 4°C and the supernatant was removed and applied to a QIAGEN-tip 100 that 
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had been previously equilibrated with 4 mL Buffer QBT. After all supernatant had run 
through the QIAGEN-tip 100 by gravity flow, the QIAGEN-tip was washed twice with 
10 mL Buffer QC. Finally, plasmid DNA was eluted from the QIAGEN-tip 100 using 5 
mL of Buffer QF. 
DNA was precipitated from this solution by adding 3.5 mL isopropanol and 
placing the samples in a -20°C freezer for at least 20 minutes. Samples were then 
centrifuged at 11,130 RPM for 30 minutes at 4°C and the supernatant was decanted and 
disposed of. The plasmid DNA pellet was washed with 2 mL 70% ethanol and 
centrifuged at 11,130 RPM for 10 minutes. Supernatant was decanted and the pellet was 
allowed to air dry for -10 minutes before being resuspended in 150 uL of deionized 
water. An ND-1000 UV/Vis Spectrophotometer was used to quantify the plasmid DNA. 
2.1.7 Preparation and Analysis of SDS-PAGE gels 
Once all of the Stxl8 truncated mutant expression plasmids were purified, initial 
protein induction experiments could be carried out. The method used to analyze protein 
induction and purification was sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). In this investigation, both 12% and 15% SDS-PAGE gels 
were used: 12% to resolve the larger recombinant proteins (Stxl8-FL, Stxl8-Ml, and 
Stxl8-M2) and 15% to resolved the smaller (Stxl8-M3 and Stxl8-M4). The method of 
preparing and visualizing these gels follows. 
2.1.7.1 Preparing 12%/15% SDS-PAGE gels 
SDS-PAGE gels are composed of two parts; a Stacking gel, where the 
protein samples are loaded, and a Resolving gel, where the protein samples are separated 
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based on their molecular weight. SDS-PAGE Stacking and Resolving gel solutions were 
prepared fresh once a month to ensure maximal gel quality. The same Stacking gel 
solution was used for both 12% and 15% SDS-PAGE gels and was prepared in the 
following way: 4.95g acrylamide, 0.13g bis-acrylamide, and O.lg SDS were dissolved in 
87.5 mL of autoclaved deionized water (dE^O). To this solution, 12.5 mL of 1M Tris-Cl 
pH 6.8 was added, bringing the total volume of the solution up to 100 mL. This solution 
was stored at 4°C in an aluminum foil-covered bottle. 
Resolving gel solutions were prepared in a similar way: 12g or 15g acrylamide, 
0.32g or 0.4g bis-acrylamide, and O.lg SDS were dissolved in 75 mL dH^O for 12% and 
15% Resolving gel solutions, respectively. These solutions were topped up to 100 mL 
with 25 mL 1.5M Tris-Cl pH 8.8 and were also stored at 4°C in aluminum foil-covered 
bottles. 
For the pouring and setting of two SDS-PAGE gels, 10 mL of either the 12% or 
15% Resolving gel solutions were obtained. To this solution, the polymerization agents 
ammonium persulphate (APS, Sigma Chemical Corp., St. Louis MO, USA) and 
N,N,N',N'-tetramethylethylenediamide (TEMED, Invitrogen, Carlsbad CA, USA) were 
added. Fresh 10% APS was made for each gel setting by dissolving 0.5g APS in 0.5 mL 
dH20. To the 10 mL Resolving gel solutions, 100 |iL APS and 9 uL TEMED were 
added. 
Gel solutions were poured between the glass plates of a Bio-Rad Mini-PROTEAN 
3 Cell apparatus (Bio-Rad, Hercules CA, USA). The setting gel was overlaid with 
saturated butanol to prevent the gel from setting with a meniscus. After allowing the gel 
to set for -30 minutes, the saturated butanol was removed and the top of the gel was 
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washed with (IH2O. The top of the gel was dried with filter paper in preparation for the 
pouring of the Stacking gel. 
To prepare the Stacking gel, 40 uL APS and 6 uL TEMED were added to 4 mL of 
Stacking gel solution. This solution was then poured onto the top of the Resolving gel, a 
10-well comb was placed into the setting Stacking gel, and the entire gel apparatus was 
wrapped in plastic wrap and stored at 4°C overnight to fully set. Gels stored at this 
temperature were good for ~1 week. 
To run protein samples on SDS-PAGE gels they must first be combined 1:1 with 
2xSDS sample loading buffer. 2xSDS sample loading buffer was prepared in the 
following way: 2.5 mL 0.5M Tris-Cl pH 6.8, 2 mL glycerol, 1 mL P-mercaptoethanol, 
0.4g SDS, and 0.02g bromophenol blue were dissolved in and topped up to 10 mL with 
dH20. This sample loading buffer was stored in an aluminum foil-covered bottle at room 
temperature. 
SDS-PAGE samples were electrophoresed in denaturing lxTris glycine buffer. 
lxTris glycine buffer was prepared 1L at a time and stored at 4°C by adding 100 mL 
lOxTris glycine solution to 900 mL dt^O. lOxTris glycine solution was prepared by 
dissolving 30.3g Tris base, 144g glycine, and lOg SDS in 1L of dH20. SDS-PAGE gels 
were run at 80V in this solution until the samples entered the Resolving gel from the 
Stacking gel, at which time the gel was turned up to 160V. Gels were run until the dye 
front ran off of the bottom of the gel. 
2.1.7.2 Visualizing SDS-PAGE gels 
In this investigation, SDS-PAGE gels were visualized by one of two ways: 
Coomassie blue staining or silver staining. For Coomassie blue staining, a Coomassie 
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blue staining solution was prepared and was composed of 0.1% (w/v) Coomassie 
Brilliant Blue R-250, 50% (v/v) methanol, and 10% (v/v) glacial acetic acid. SDS-PAGE 
gels were immersed in this solution in a plastic container on a stir plate and incubated at 
room temperature overnight. The stained gels were then rinsed with dH20 and immersed 
in Coomassie blue destaining solution, which was composed of 40% (v/v) methanol and 
10% (v/v) glacial acetic acid. Gels were incubated on a stir plate at room temperature 
until the desired level of destaining had been achieved. Destained gels were then 
visualized using a Chemlmager (Alpha-Innotech Corp., San Leandro CA, USA) via 
transillumination. 
For silver staining of SDS-PAGE gels, a Bio-Rad Silver Stain Plus kit was used. 
Gels were first fixed for 20 minutes in Fixative Enhancer Solution, which was composed 
of 50% (v/v) methanol, 10% (v/v) glacial acetic acid, and 10% (v/v) Bio-Rad Fixative 
Enhancer Concentrate. After fixing, gels were rinsed twice for 10 minutes in 400 mL 
dt^O. To the rinsed gels, 50 mL of Silver Staining Solution (35 mL dE^O, 5 mL Bio-
Rad Silver Complex Solution, 5 mL Bio-Rad Reduction Moderator Solution, and 5 mL 
Bio-Rad Image Development Reagent) was added. Gels were agitated in this solution on 
a stir plate until the desired level of staining was achieved. Staining was stopped by 
pouring off the Silver Staining Solution and immersing the gels in 5% (v/v) glacial acetic 
acid for 15 minutes. Gels were then rinsed thoroughly in dl-bO and visualized using the 
Chemlmager via transillumination. 
2.1.8 Small-scale induction of transformed E. coli BL21 cells 
In order to determine the optimal time to harvest induced E. coli BL21 cells, a 
small-scale induction was carried out for each of the five proteins to be expressed. Two 
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samples of approximately 300 uL overnight positive-clone culture were used to inoculate 
two flasks containing 20 mL LB broth containing 20 ug/mL kanamycin sulphate. One 
flask was labeled 'uninduced' to serve as a negative control and the other was labeled 
'induced'. Flasks were incubated with agitation at 37°C until they reached an OD600 in 
the range of 0.5-0.7. At this time, isopropyl-p-D-thiogalactopyranoside (IPTG) 
(Invitrogen) was added to the 'induced' flask to a final concentration of 1 mM. Both 
flasks were then incubated at 37°C with agitation for 12 hours. Aliquots were removed 
from each flask at the following time intervals: t = 0, 1, 2, 3, 5, 7 and 12 hours. A 2 mL 
aliquot was removed from each flask at the t = 0 time point and the OD600 was measured. 
At each time interval, the ODgoo was measured again and used to calculate a volume of 
cell suspension to remove in order to approximate an equal amount of cells between all 
aliquots. Aliquots were then pelleted by centrifugation at 10,000 RPM in an Eppendorf 
5415R centrifuge for 10 minutes and following removal of the supernatant, cell pellets 
were stored at -80°C. When ready for analysis, pellets were resuspended in 150 uL of 
lxSDS loading dye, boiled for 3 minutes, and 10 uL aliquots for each time interval were 
loaded on either 12% or 15% SDS-PAGE gels (percentage of gel dependant on projected 
size of mutant protein). 
It was during the induction of small-scale recombinant protein samples that many 
optimization experiments were carried out. In order to determine the best way to induce 
Stxl8 recombinant proteins, the above general outline was followed with changes in 
aspects such as growth conditions (temperature) and the strain of expressing host 
bacteria. Different growth temperatures, nominally 4°C, room temperature, and 37°C, 
were used when attempting to express a potentially soluble form of Stxl 8 recombinant 
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protein. Furthermore, in order to try to achieve maximal induction efficiency, E. coli 
expression strains such as BL21, BL21-pLysS, and Rosetta2 were used. All these strains 
offer different characteristics with the intent of providing a stable, efficient host induction 
system, and after small-scale optimization experiments were carried out with both 
pHTT7K and pET28a expression vectors, it was decided that E. coli BL21 cells were 
sufficient for the purposes of this investigation. 
2.1.9 Determination of induced protein solubility 
The solubility of Stxl 8-M1 (see Table 2.4) protein was determined in order to 
decide whether purifications would be done under denaturing or non-denaturing 
conditions. To this effect, Protocol 6 found in the QIAexpressionist (Qiagen) was used. 
Five mL of an overnight starter culture of the mutant-expressing bacteria was used to 
inoculate 50 mL of LB broth containing 50 ug/mL kanamycin sulphate. Cultures were 
incubated with agitation at 37°C until they reached an OD600 of 0.5-0.7. A 1 mL sample 
(uninduced control) was then taken immediately before induction, the cells were pelleted, 
and the pellet resuspended in 50 uL lxSDS-PAGE sample buffer. Expression of mutant 
protein was then induced by the addition of IPTG to a final concentration of 1 mM to the 
remaining culture. Cultures were incubated with agitation at 37°C for a further 4 hours, 
after which time another 1 mL sample (induced control) was taken and treated similarly 
to the uninduced control; the pellet was resuspended in 100 uL of lxSDS-PAGE sample 
buffer to correct for the higher cell density in the induced control. Cells were harvested 
from the remaining culture by centrifugation at 5,750 RPM in a Beckman Coulter Avanti 
HP-20 XPI centrifuge for 20 minutes and the pellet was frozen at -20°C. 
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The frozen cell pellet was resuspended in 5 mL of lysis buffer for native 
purification (50 mM NaH2P04, 300 mM NaCl, 10 mM imidazole, pH 8.0; The 
QIAexpressionist), lysozyme was added to a final concentration of 1 mg/mL and the 
suspension was incubated on ice for 30 minutes. The suspension was then sonicated six 
times for 10 seconds, with 10 second pauses, at 200-300W on a Fisher Scientific Sonic 
Dismembrator Model 100 (Fisher Scientific, Pittsburgh PA, USA). The cell lysate was 
kept on ice throughout the sonication process. The lysate was centrifuged at 10,400 RPM 
in an Eppendorf 5415R centrifuge at 4°C for 25 minutes, and the supernatant was 
decanted, labeled Crude Extract A (soluble protein) and saved on ice. The pellet was 
resuspended in 5 mL lysis buffer and labeled Crude Extract B (a suspension of insoluble 
matter and protein). Five uL of both Extracts A and B were added to 5 uL aliquots of 
2xSDS-PAGE sample buffer in Eppendorf tubes. These tubes, along with the uninduced 
and induced samples taken previously, were boiled for 5 minutes and loaded on a 12% 
SDS-PAGE gel. 
To be sure that the expressed Stxl8-Ml protein was indeed insoluble and not just 
associated with membrane fragments in the cell pellet, another solubility test was 
performed. The second solubility test was identical to the first, except that after the 
soluble Crude Extract A was decanted, the insoluble pellet was extracted with 5 mL of a 
0.25% Tween-20, 0.1 mM EGTA solution. After centrifugation the supernatant was 
decanted and labeled 'Pellet Extract', and the pellet was once again resuspended in 5 mL 
lysis buffer and labeled Crude Extract B. 
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2.1.10 Large-scale induction of transformed E. coli BL21 cells 
Approximately 2 mL of overnight culture harbouring the plasmid to be expressed 
was used to inoculate 150 mL of LB broth containing 50 ug/mL kanamycin sulphate. 
Culture was grown at 37°C with agitation until the ODgoo reached 0.5-0.7. IPTG was 
added to the culture to a final concentration of 1 mM and the culture was grown for a 
further 4 hours at 37°C with agitation. Induced cell culture was then aliquoted into 10 
mL portions and cell pellets were harvested by centrifugation at 5750 RPM in a Beckman 
Coulter Avanti HP-20 XPI centrifuge for 15 minutes. Cell pellets were stored at -80°C 
until purification attempts were made. 
2.1.11 Protein purification under denaturing conditions 
Following the determination of the solubility of Stxl8-Ml in the step outlined 
above, it was decided that all expressed proteins would be purified under denaturing 
conditions using Qiagen's nickel-nitrilotriacetic acid (Ni-NTA) metal affinity spin kit 
(QIAGEN Montreal, QC). Induced cell pellets were thawed for 15 minutes at room 
temperature and resuspended in 1 mL of Buffer B (see composition in Table 5). Cell 
suspensions were incubated with agitation for 4 hours at room temperature. Cell lysate 
was centrifuged after this period at 10,400 RPM in an Eppendorf 5415R centrifuge for 25 
minutes at room temperature in order to pellet the cellular debris. Supernatant was 
collected and labeled Cleared Lysate. 
A Qiagen Ni-NTA mini-spin column was equilibrated by adding 600 uL Buffer B 
and centrifuging the column for 2 minutes at 2,700 RPM in an Eppendorf 5415R 
centrifuge. 600 uL of Cleared Lysate (containing expressed 6xHis-tagged recombinant 
protein) was then added to the column and centrifuged at 2,700 RPM for 2 minutes. The 
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flow-through was collected and saved for later analysis. The Ni-NTA mini-spin column 
was then washed twice with 600 uL portions of Buffer C, followed by centrifugation at 
2,700 RPM for 2 minutes. Wash fractions were collected and saved for analysis. 
Table 5: Reagents used in the purification, dialysis and analysis of 6xHis-tagged 
recombinant proteins 
Reagent Reagent Composition 
Buffer B 8 M urea (Sigma), 0.1M NaH2P04 (Sigma), 0.01M Tris-Cl 
(Sigma); pH 8.0 
Buffer C Same as above; pH 6.3 
Buffer E 
lxSDS loading dye 
Coomassie blue 
staining solution 
Coomassie blue 
destaining solution 
Protein dialysis 
buffer 
Same as above; pH 4.5 
25 mM Tris-Cl, 20% (v/v) glycerol, 0.2% (w/v) bromophenol 
blue, 4% (w/v) SDS, 0.1% (v/v) p-mercaptoethanol 
50% methanol, 10% acetic acid, 1% (w/v) Coomassie Brilliant 
Blue R-250 
50% methanol, 10% acetic acid 
100 mM KC1, 10% (w/v) glycerol, 1 mM L-glutathione Reduced, 
0.1 mM oxidized glutathione, 0.01% (v/v) Triton X-100, 20 mM 
triethanolamine. Multiple dialysis buffers were made with the 
above concentrations of components, differing only in urea and 
pH in order to form the following gradient: 6M urea/pH 5.0,4M 
urea/pH 5.5, 2M urea/pH 6.0, 1M urea/pH 6.7, 0M urea/pH 7.4 
A Qiagen Ni-NTA mini-spin column was equilibrated by adding 600 |JL Buffer B 
and centrifuging the column for 2 minutes at 2,700 RPM in an Eppendorf 5415R 
centrifuge. Six hundred |iL of Cleared Lysate (containing expressed 6xHis-tagged 
recombinant protein) was then added to the column and centrifuged at 2,700 RPM for 2 
minutes. The flow-through was collected and saved for later analysis. The Ni-NTA mini-
spin column was then washed twice with 600 uL portions of Buffer C, followed by 
centrifugation at 2,700 RPM for 2 minutes. Wash fractions were collected and saved for 
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analysis. Expressed protein was eluted from the column twice by adding 200 uL of 
Buffer E and centrifuging the column at 2,700 RPM for 2 minutes. The two elution 
fractions were combined for a total volume of 400 uL eluted protein and saved. This 
general procedure was the most commonly used; however, sometimes more wash steps 
were used in which wash buffers with pHs ranging from pH 6.5 to 5.9 were used in order 
to allow for more stringent wash conditions. 
Purified protein fractions were analyzed by SDS-PAGE. Approximately 10 uL 
aliquots from the cleared lysate, flow-through, wash and elution fractions were combined 
with an equal volume of lxSDS loading dye. Samples were boiled for approximately 2 
minutes and loaded onto a 15% SDS-PAGE gel. 
2.1.12 Protein dialysis 
Purified proteins were dialyzed using a stepped urea/pH gradient in order to 
remove the denaturing urea from the sample and bring the pH back up to near-neutral. 
Approximately 2 mL of purified proteins in Buffer E (containing ~1 mg total protein) 
were transferred to Slide-A-Lyzer 10,000 MWCO 0.5-3 mL capacity dialysis cassettes 
(Pierce, Rockford IL, USA). Cassettes were placed in beakers containing 750 mL of 
protein dialysis buffer for at least 3 hours per buffer change with gentle stirring at 4°C. 
Dialysis consisted of the following stepped-gradient protein dialysis buffer changes (see 
Table 5): 6M urea/pH 5.0,4M urea/pH 5.5, 2M urea/pH 6.0, 1M urea/pH 6.7 and 0M 
urea/pH 7.4. Once dialysis was complete, protein samples were removed from the 
cassettes and transferred to 1.5 mL Eppendorf tubes. Samples were quantified using a 
Bio-Rad protein quantification assay and analyzed by 15% SDS-PAGE followed by 
Western blotting to confirm the presence of target protein. 
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2.1.13 Detection of target protein by Western blotting 
At various times throughout this investigation, it was desirable to ensure that 
target Stxl8 truncated mutant proteins were present in a given sample. To this effect, a 
primary polyclonal antibody for use in immunoprecipitation experiments and Western 
blotting was generated in rabbits by Invitrogen. As this investigation dealt with C-
terminal deletion mutants of the Stxl8 protein, a 15 amino acid residue polypeptide near 
the N-terminal portion of the Stxl8 protein was used to generate the antibody (see Table 
6) such that all truncated Stxl8 mutants would be detectable by it. 
Samples to be tested for target protein presence by Western blotting were first 
diluted 1:1 in 2xSDS-PAGE loading dye and boiled for 3 minutes, followed by loading 
onto a 15% SDS-PAGE gel. One lane was always reserved in such gels for running 10 
uL of wide-range (10-250 kDa) Rainbow marker (Amersham Biosciences, now part of 
GE Healthcare Biosciences Inc., Piscataway NJ, USA), as this marker is readily visible 
on the nitrocellulose membrane post-transfer, indicating successful protein transfer. Gels 
were separated from the glass plates and put into transfer buffer (see Table 7) along with 
one sheet of nitrocellulose (optitran BA-S 85 reinforced NC, Whatman GmbH, Dassel, 
Germany), 4 sheets of filter paper and 2 sponges (per gel). These components were 
soaked in the transfer buffer for 15 minutes before the transfer sandwich was assembled 
and placed into an electrophoresis box containing transfer buffer. An ice block was 
added to the transfer apparatus to keep it cool and was then run at 100V with stirring by a 
magnetic stir bar for 1 hour. After one hour, the sandwich was disassembled and the 
nitrocellulose carefully examined to ensure that protein transfer was successful, as 
indicated by the visible presence of the Rainbow marker mentioned previously on the 
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Table 7: Reagents used for Western blot analyses 
Reagent Reagent Composition 
Transfer buffer 0.025M tris base, 0.192M glycine, 20% (v/v) methanol 
5% milk/TBS solution 5% (w/v) milk, 0.9 % (w/v) NaCl, 10 mM tris, pH 7.2 
0.5% milk/TBS solution 0.5% (w/v) milk, 0.9% (w/v) NaCl, 10 mM tris, pH 7.2 
membrane. The nitrocellulose membrane was then blocked by placing it in a dish 
containing 50 mL of a 5% milk/TBS solution (see Table 7). This dish was agitated on a 
stir plate overnight at 4°C. 
After blocking, the nitrocellulose membrane was washed with ~40 mL of a 0.5% 
milk/TBS solution (see Table 7) for 5 minutes; the solution was then poured off. Stxl8 
primary polyclonal antibody (Invitrogen) was then diluted 1:3600 in 40 mL of the 0.5% 
milk/TBS solution and this was added to the dish containing the membrane and incubated 
at room temperature for 1 hour with agitation. The primary antibody solution was poured 
off and the membrane was washed three times with 40 mL portions of 0.5% milk/TBS for 
5 minutes each. Anti-rabbit secondary IgG antibody (Promega, Madison WI) was then 
diluted 1:1800 in 40 mL of 0.5% milk/TBS and added to the dish containing the 
membrane. The dish was incubated at room temperature for 30 minutes with agitation. 
The membrane was then washed three times with 40 mL portions of 0.5% milk/TBS for 
10 minutes each. The membrane was then incubated for ~1 minute with SuperSignal 
Picowest Chemiluminescent substrate, which was prepared by combining 1.5 mL each of 
SuperSignal West Pico Stable Peroxide Solution and SuperSignal West Pico 
Luminol/Enhancer Solution (Pierce, Rockford IL); the membrane was visualized using a 
Chemlmager (Alpha Innotech, San Leandro CA). 
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2.2 Results and Discussion 
Electrotransformation of E. coli DH5a cells with ligation mixes was successful in 
producing bacterial colonies on kanamycin selective media in all cases; the negative 
control plates had fewer colonies, or no colonies at all, in each case when compared to 
the experimental plates. The presence of colonies on the kanamycin selective media 
suggested that ligation reactions were successful, as a complete circular plasmid is 
required for the kanamycin resistance gene to be active. Single colonies from each 
ligation reaction plate were picked and grown overnight in order to perform a small-scale 
plasmid purification. Once plasmid was purified for each ligation reaction, restriction 
digests with Ndel and Sacl were performed to analyze whether or not plasmids had 
correctly-sized inserts for generation of each of the Stx 18 truncated mutants. 1 % agarose 
electrophoretic gel analyses of these restriction digests for Stx 18 mutants 1-4 plasmids 
are shown in Figure 9. 
The analysis of Stxl8-Ml (Figure 9A) shows inserts of the expected size isolated 
from colonies 11 and 12 (lanes 6 and 7). Colonies 9 and 10 (lanes 4 and 5) show no 
insert whatsoever upon digestion with Ndel and Sacl, indicating that these false-positive 
colonies were most likely due to intact pHTT7K plasmid being transformed into the 
bacterial cells. Similar results are seen in the analyses of Stxl8-M3 and Stxl8-M4 
(Figures 11C and D); inserts of the correct size are shown (Figure 9C lanes 3-5 and 
Figure 9D lanes 3 and 7), whereas the lanes showing no insert are false-positives. The 
analysis of Stxl8-M2 positive clones looks different from the others in that all colonies 
had inserts, although only that in lane 6 is a true positive clone. The other lanes have 
inserts simply because the plasmid used for ligation reactions was pHTT7K-Stxl8-FL 
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Figure 9: Agarose gel analysis of Stxl8Ml-M4 mini-digests with Ndel and Sad. 
Colonies resulting from ligation-mix transformations of E. coli BL21 (DH5a) cells were 
mini-digested with Ndel and Sacl. Samples were run on 1% agarose gels to search for 
inserts, indicating positive clones; (A) Stxl8-Ml, (B) Stxl8-M2, (C) Stxl8-M3 and (D) 
Stxl8-M4. 
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digested with Ndel and Sad rather than just pHTT7K; the other inserts seen are the 
Stxl8-FL insert. Once positive colonies had been identified for all Stxl8 truncated 
mutants, duplicate samples of each were grown up for the purpose of purifying plasmid 
from them. Purified plasmids were then sent to Macrogen, South Korea for sequencing 
and all plasmids complete with inserts were found to be error-free (data not shown). 
Sequenced plasmids were transformed into E. coli BL21 cells for expression of 
recombinant proteins via IPTG induction. Time-course inductions of Stxl8-FL and 
Stxl8-Ml recombinant proteins are shown in Figure 10. It is readily apparent that 
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 
Figure 10: SDS-PAGE analysis of time-course inductions of 6xHis-tagged Syntaxin 
18 FL and Ml recombinant proteins. Cell pellets collected at various time points 
during induction via IPTG were prepared and loaded on 12% SDS-PAGE gels and 
visualized by Coomassie staining; (A) Stxl8-FL and (B) Stxl8-Ml. 
induction of full-length Syntaxin 18 failed to express any appreciable amount of the 
recombinant protein (Figure 10A); all bands in all lanes exhibit approximately the same 
degree of intensity, suggesting no induction whatsoever, particularly when comparing the 
twelve hour induced and uninduced samples (lanes 8 and 9). This phenomenon is most 
likely explained by the fact that full-length Syntaxin 18 contains a C-terminal 
transmembrane domain. Transmembrane proteins are notoriously difficult to express as 
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overexpression, in many cases, has a toxic effect on cells, preventing cell growth and 
limiting protein yields (Selinsky, 2003). Stxl8-Ml, however, was readily expressed to a 
high degree as can be seen by the -42 kDa band of increasing intensity seen in Figure 
10B lanes 2-8. The success of Stxl8-Ml expression compared to Stxl8-FL can be 
attributed to the lack of the transmembrane domain in Stxl 8-M1 (see Table 6). After 
successful induction of Stxl8-Ml, solubility tests were performed in order to decide how 
to proceed with purification experiments. Results of solubility tests are shown in Figure 
11. 
1 2 3 4 5 1 2 3 4 5 6 
Figure 11: SDS-PAGE analysis of Stxl8-Ml solubility determinations. Stxl8-Ml 
was subjected to two solubility tests as outlined in Methods above. Stxl8-Ml solubility 
was the determining factor of whether recombinant proteins would be purified by 
denaturing conditions or not; (A) solubility test 1 and (B) solubility test 2. 
The two solubility tests depicted in Figure 11 were identical except for the 
addition of one step for the second test (Figure 1 IB, lane 5), as described in the Methods 
section. Both solubility tests show that Stxl8-Ml, as expressed, is an insoluble protein 
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due to the appearance of the intense -42 kDa band in the insoluble fraction (Figure 11A 
lane 5 and Figure 1 IB lane 6). This information was the determining factor upon which 
denaturing protocols were chosen for use during purification experiments. 
After determining the solubility of Stxl8-Ml, time-course inductions of the other 
three Stxl8 truncated mutants were performed. Analyses of these inductions on 15% 
SDS-PAGE gels are shown in Figure 12. Stxl8-M2 was successfully induced and 
expressed as can be seen by the ~26 kDa band of increasing intensity shown in Figure 
12A lanes 2-8. Stxl8-M4 was also successfully induced and expressed as indicated by 
the presence of a -7 kDa band in Figure 12C lanes 3-7. Interestingly, this band does not 
increase in intensity, but its size and the lack of this band in lanes 2 and 8 (induced time = 
0 hours and uninduced time = 7 hours, respectively) suggests that this is indeed Stxl8-
M4. Unfortunately, Stxl8-M3 failed to be induced and expressed as indicated by the lack 
of any new bands between induced and uninduced samples in Figure 12B. It is 
interesting to note that induction of Stxl8-M3 appeared to exhibit some kind of toxicity 
on the bacterial cells. This toxicity was evident by the fact that, upon induction of the 
bacterial culture at ODeoo ~0.5 with IPTG, the induced culture lost cell density at a rate 
not seen for any of the other Syntaxin 18 mutants (data not shown). 
For all Stxl8 recombinant protein expressions, the induced cultures had depressed 
cell densities relative to their uninduced counterparts; however, while depressed, they 
still exhibited increasing cell growth from the starting optical density of ODgoo -0.5. 
Stxl8-M3 bacterial culture, on the other hand, lost cell density immediately upon IPTG 
induction, and after the first hour the ODgoo was below the starting point of -0.5. This 
deletory effect that induction of Stxl8-M3 had upon the expressing E. coli BL21 cells is 
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the most likely reason why induction/expression of the recombinant protein was 
unsuccessful. However, the reason why induction of Stxl8-M3 has such an effect on the 
expressing bacterial cells is unknown and perhaps worthy of future investigation. 
Upon study of the analyses of time-course inductions, it was decided that 4 hours 
induction was sufficient to express enough recombinant protein for purification purposes 
Figure 12: SDS-PAGE analysis of time-course inductions of 6xHis-tagged Syntaxin 
18-M2, -M3 and -M4 recombinant proteins. Cell pellets collected at various time 
points during induction via IPTG were prepared and loaded on a 12% (A) and 15% (B 
and C) SDS-PAGE gels and visualized by Coomassie staining; (A) Stxl8-M2, (B) 
Stxl8-M3 and (C) Stxl8-M4. 
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using Ni-NTA affinity columns. During the purification process flow-through, wash and 
elution fractions were kept for analysis. Samples of each were run on 12%-15% SDS-
PAGE gels, and results are shown in Figure 13. 
Purification of Stxl8-Ml and Stx-M2 were highly successful as indicated by the 
intensity of their respective bands in the elution fractions (lane 10, Figures 15A and B). 
This suggests that the 6xHis-tag at the N-terminus of these recombinant proteins readily 
bound to the Ni-NTA matrix. Having much smaller molecular weights than 
Figure 13: SDS-PAGE analysis of Nr+-NTA purified 6xHis-tagged Stxl8 
recombinant proteins. Purification samples were loaded on 12% (A and B) and 15% 
(C and D) SDS-PAGE gels and visualized by Coomassie staining (A and B) and silver 
staining (C and D); (A) Stxl8-Ml, (B) Stxl8-M2, (C) Stxl8-M3 and (D) Stxl8-M4. 
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Stxl8-Ml and Stxl8-M2, Stxl8-M3 and Stxl8-M4 purification analyses were visualized 
not by Coomassie staining, but by silver-staining due to its higher sensitivity. 
Unfortunately, as expected from the analysis of the time-course induction, purification of 
Stxl8-M3 was unsuccessful (Figure 13C), despite several attempts involving modified 
growth conditions and different bacterial expression strains. The increased level of 
bacterial cell death observed during Stxl8-M3 induction resulted in cleared lysate that 
was deficient of enough target recombinant protein to be successfully purified using the 
Ni-NTA technology; Western blot analyses of Stxl8-M3 induced cleared lysates 
indicated that target recombinant protein was indeed present, but at much lower levels 
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Figure 14: Western blot analysis of human Stxl8 8M urea purification pH 4.5 
elution fractions. Rainbow marker (Lane 1) was used for size determination of bands. 
Lanes 2, 3 and 6 were successfully purified Stxl8-Ml, -M2 and -M4 as determined by 
Coomassie staining. Despite unsuccessful purification (as determined by Coomassie 
staining) of Stx8-M3, two separate purification attempts of Stxl8-M3 were analyzed as 
well (Lanes 4-5) to confirm unsuccessful purification. 
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than that seen for any of the other recombinant proteins investigated (data not shown). 
Stxl8-M4 purification was a success, however, as indicated by the band in the elution 
fraction at ~7 kDa (Figure 13D). 
Purified protein pH 4.5 elution fractions were analyzed by Western blotting to 
confirm that the band appearing by Coomassie staining was indeed a derivative of human 
syntaxin 18. Primary antibody used for Western blotting was generated in rabbits by 
Invitrogen using a short N-terminal syntaxin 18 polypeptide (see Table 6). Results of 
Western blot analysis of the purified protein samples are shown in Figure 14. Stxl8-Ml, 
-M2 and -M4 are clearly shown to have been successfully purified, although Stxl8-Ml 
appears to have undergone significant degradation over the length of time spent in the 
freezer that passed between initial purification and the performance of this analysis. 
Multiple freeze-thaw cycles that this sample was subjected to over the duration since 
initial purification would account for this degradation. Still, the intact protein is by far 
the most significant in both the Stxl8-Ml and -M2 samples. Stxl8-M4 successfully 
purified as well, although the band is quite diffuse. There is also a faint band for Stxl 8-
M4 that appears above the most significant band, appearing to be approximately 13 kDa 
in size; perhaps, due to its small size, Stxl8-M4 can form dimers with itself and this is 
the reason for the faint, larger band. Western analysis also confirmed the conclusion that 
Stxl8-M3 was not successfully purified; no bands appeared in either of the two StxIS-
MS samples. 
Based on the above findings that Stxl 8-M3 would be difficult to express 
and purify, it was decided that all further work would first focus on the larger human 
Stxl8 recombinant proteins: Stxl8-Ml and Stxl8-M2. Unfortunately, protein induction 
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and expression with the pHTT7K expression vector in which the recombinant protein 
sequences were ligated ceased to be successful. Due to a course of many unsuccessful 
trials to re-induce expression of pHTT7K-Stxl8-Ml and pHTT7K-Stxl8-M2 via IPTG 
induction, it was decided to religate the Stxl8-Ml and Stxl8-M2 sequences into a new 
expression vector; the reason for the sudden failure of these vectors to express 
recombinant protein via IPTG induction is unknown. The new commercial expression 
vector, Novagen's pET28a, was bought and used instead. Stxl8-Ml and Stxl8-M2 
inserts were ligated into the new expression vector and complete, working plasmid 
constructs were soon available for the re-expression and purification of both proteins. 
Stxl8-Ml and Stxl8-M2 were both successfully induced and purified using the new 
expression vector system and results, including a Western blot analysis confirming the 
identity of Stxl8-Ml and -M2 using anti-Stxl8 antibody, are shown in Figure 15. 
Figure 15A depicts the purification of Stxl 8-M1. A clear band appears in the 
elution fraction (lane 5) indicating that the recombinant protein readily bound to the Ni-
NTA matrix. Similar results are seen for the purification of Stxl8-M2, shown in Figure 
15B. A clear eluting band can be seen in Lane 8. A Western blot was performed to 
confirm the present of truncated Stxl8 recombinant proteins using the same anti-Stxl8 
antibody used in previous experiments. Figure 15C shows that these proteins were 
indeed successfully purified (lanes 2 and 3) and therefore continuation with further 
experiments to determine whether or not these recombinant proteins exhibited 
endonucleolytic activity was deemed possible. 
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Figure 15: Stxl8-Ml and -M2 purifications and Western blot analyses post-pET28a 
induction. A new expression vector, Novagen's pET28a, was used to induce and purify 
Stxl 8-M1 and -M2 after failure of the original expression vector, pHTT7K. (A) Stxl8-
Ml purification, (B) Stxl8-M2 purification and (C) Western analysis confirming 
successful Stxl8-Ml and -M2 purification. 
Dialysis of purified recombinant proteins was performed successfully, with no 
significant loss of protein due to aggregation and/or precipitation. Concentrations of 
dialyzed protein samples were typically diluted from the original concentration, as 
dialysis procedures used in this investigation tended to result in an approximately 25% 
increase in sample volume post-dialysis. However, this had little to no affect on future 
experiments as total protein amounts were unaffected. 
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Chapter 3 
Testing the Ability of Truncated Syntaxin 18 mutants to cleave c-myc 
CRD RNA 
This chapter describes the experimental approach used to investigate potential 
endonucleolytic activity of truncated recombinant human syntaxin 18 proteins on c-myc 
CRD RNA. Initially, c-myc CRD RNA was transcribed, purified, dephosphorylated and 
5'-radiolabelled for detection of fragments via autoradiography. Following dialysis of 
His6-tagged Ni-NTA purified recombinant protein, further purification steps were 
performed (such as immunoprecipitation and size-exclusion gel filtration 
chromatography) in order to obtain as pure a sample of recombinant protein as possible. 
Purified recombinant protein samples were then assayed for their ability to cleave mRNA 
using the standard endonuclease assay. Furthermore, this chapter covers the presentation 
and critical analysis of experimental results. A rationale for the use of c-myc CRD RNA 
will also be discussed. 
3.1 Methodology 
3.1.1 Plasmid digestion 
The first step in generating RNA via in vitro transcription involved the 
linearization of the plasmid which contains the DNA sequence for the corresponding 
RNA to be transcribed. For the investigation carried out here, the vector in question was 
a pUC19 construct containing a portion of the c-myc coding region determinant (CRD) 
sequence, nucleotides 1705-1792; RNA generated from this plasmid construct was called 
'c-myc CRD RNA'. Generally, 5 ug of the plasmid were obtained for linearization with 
EcoRl restriction enzyme in appropriate reaction buffer; total reaction volumes were 30 
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JLIL. Linearization reactions were incubated at 37°C for 90 minutes. Immediately after 
digestion 10 uL 20% SDS and 5 uL 10 mg/mL Proteinase K were added to the reactions 
and samples were then incubated at 50°C for a further 15 minutes. Following this final 
incubation, the reactions were quenched by adding 155 uL diethylpyrocarbonate (DEPC) 
(Sigma)-treated water, bringing total sample volumes up to 200 uL. 
Linearized c-myc CRD plasmid was obtained via the standard phenol/chloroform 
extraction followed by standard ethanol precipitation. One volume (100 uL) phenol and 
one volume (100 uL) 49:1 chloroform:isoamyl alcohol were added to the 200 uL samples 
and mixed thoroughly. Samples were centrifuged at 13,200 RPM for 5 minutes and the 
aqueous layer was extracted and placed into a fresh 1.5 mL Eppendorf tube. 2 volumes 
(200 uL) of 49:1 chloroform: isoamyl alcohol was then added and mixed thoroughly, 
followed by centrifugation at 13,200 RPM for 5 minutes. The aqueous layer was once 
again extracted and placed into a fresh 1.5 mL Eppendorf tube and the DNA was 
precipitated by the addition of 1/10 volume (20 uL) 5M sodium acetate and 2 volumes 
(200 uL) cold 100% ethanol. Samples were placed in the -20°C freezer for at least 30 
minutes to enhance and facilitate precipitation. Samples were then centrifuged at 13,200 
RPM for 30 minutes at 4°C and the supernatant was carefully removed. The DNA pellet 
was washed with 200 uL cold 70% ethanol and centrifuged at 13,200 RPM for a further 
15 minutes. Following centrifugation, the supernatant was carefully removed and 
samples were allowed to air dry for 10 minutes before resuspending the pellet in 20 uL 
DEPC-treated water. Linearized DNA concentrations were determined using an ND-
1000 UV/Vis Spectrophotometer (Nanodrop Technologies, Wilmington DE) and samples 
were checked for complete linearization by 1 % agarose gel electrophoresis. 
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3.1.2 Generation of unlabelled c-myc CRD RNA 
Unlabelled c-myc CRD RNA was generated from the linearized c-myc CRD 
plasmid construct using an SP6 RNA polymerase-based in vitro MEGAscript 
transcription kit (Ambion, Austin TX, USA). One ug linearized plasmid, 2 uL each of 
dNTPs (dATP, dGTP, dCPT and dUTP; 5 mM each final concentration), 2 uL SP6 RNA 
polymerase, 1 uL (40U) RNasin (Promega, Madison WI, USA), 1 uL 100 ng/mL 
dithiothreitol (DTT) (Promega), 2 uL 10X SP6 transcription reaction buffer and 5.5 uL 
DEPC-treated water were added to a 1.5 mL Eppendorf tube, with a final reaction volume 
of 20 uL. Reaction tubes were incubated at 37°C for 2 hours, with an additional 1 uL 
RNasin added after 1 hour. One uL DNase was added to reaction tubes, followed by a 
further 15 minutes incubation at 37°C, to destroy the template DNA. Total reaction 
volume was then made up to 100 uL with DEPC-treated water for extraction via the 
standard phenol/chloroform method, outlined previously. RNA pellets were resuspended 
in 20 uL DEPC-treated water and quantified using the ND-1000 UV/Vis 
Spectrophotometer. RNA quality was determined by running 1 uL of resuspended RNA 
on a 2.5% agarose gel at 20 mA for approximately 1.5 hours. 
3.1.3 Dephosphorylation of c-myc CRD RNA 
In order to radioactively label c-myc CRD RNA, the molecules first had to be 
dephosphorylated. Dephosphorylation was carried out on 5 ug of RNA at a time. To the 
RNA, 5 uL 100 mM DTT (Promega), 30U RNasin (Promega), 10U calf intestine alkaline 
phosphatase (GE Healthcare), lx Dephosphorylation buffer (GE Healthcare) and DEPC-
treated water were added to a final volume of 100 uL. Reaction tubes were incubated at 
37°C for 30 minutes. After incubation 100 uL DEPC-treated water was added, bringing 
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the total volume up to 200 |iL. One uL 0.5M (ethylenediaminetetraacetic acid) EDTA 
(EM Science, Gibbstown NJ, USA) pH 8.0, 4 uL 5M sodium chloride (NaCl) (Sigma 
Chemical Co., St. Louis MO, USA) and 10 uL 20% sodium dodecyl sulphate (SDS) (EM 
Science) were added to the reaction tubes. Dephosphorylated c-myc CRD RNA was then 
recovered by the standard phenol/chloroform extraction followed by a standard ethanol 
precipitation. RNA pellets were resuspended in 20 uL DEPC-treated water. 
3.1.4 Generation of 5'-radiolabelled c-myc CRD RNA 
Approximately 2 ug dephosphorylated RNA was radioactively labeled at a time. 
To the RNA, 1 uL 100 mM DTT, 15U RNasin, 2.5 uL lOx phosphorylation buffer (New 
England Biolabs, Ipswich MA, USA), 60 uCi y32-P ATP (Amersham Biosciences), 30U 
T4 polynucleotide kinase (New England Biolabs) and DEPC-treated water was added to a 
final volume of 25 uL. The reaction tubes were incubated at 37°C for 1 hour. Twenty 
five uL of RNA phenol loading dye (0.02% xylene cyanol, 0.02% bromophenol blue, 
10% phenol, 9M urea) was added to the reaction tubes and the total contents were loaded 
onto a 5% denaturing polyacrylamide (29:1, acrylamide:N,N'-methylenebisacrylamide) 
gel containing 7M urea (Invitrogen). The gel was run at 25 mA until the dye front 
reached the bottom of the gel. Radioactively labeled RNA was visualized using a 
Cyclone Storage Phosphor Screen System (Packard, Meriden CT, USA). An 
autoradiograph depicting the bands was printed out at actual size (scale 1:1) and the 
positioning of the bands on the autoradiograph was used to identify where in the gel 
appropriate bands for recovery were located. Appropriate bands were excised from the 
gel and placed in 1.5 mL Eppendorf tubes along with 600 uL probe elution buffer (7.5M 
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NH4OAc, 0.5M EDTA pH 8.0, 20% SDS, Yi volume phenol and Vi volume chloroform) 
and were incubated at 45 °C for 5 hours. 
RNA-containing solution was recovered from elution tubes by centrifuging the 
tubes at 13,200 RPM for 5 minutes and removing the liquid to new 1.5 mL Eppendorf 
tubes. Radioactively labeled RNA was recovered by standard phenol/chloroform 
extraction followed by standard ethanol precipitation. RNA pellets were resuspended in 
150 uL DEPC-treated water. 5'-radiolabeled RNA activities (counts per minute/cpm) 
were determined using a Packard 1600 TR liquid scintillation analyzer. Radioactively 
labeled RNA preparations were maintained at -100,000-150,000 cpm and stored in 
shielding plastic boxes at -20°C. 
3.1.5 Generation of Seize X Protein A Immunoprecipitation columns 
In an attempt to be certain of the purity of human Stxl8 truncated mutants, two 
immunoprecipitation experiments were performed using a Pierce Seize X Protein A 
Immunoprecipitation Kit (Pierce, Rockford IL, USA). This kit aims to purify antigens 
using an introduced primary antibody that can be permanently bound to the Protein A gel 
within the column, such that only target protein should be present after elution. Identity 
and composition of kit reagents are presented in Table 8. 
Immunoprecipitation columns were generated according to the kit instructions. 
Immobilized Protein A and other kit reagents were allowed to equilibrate to room 
temperature, and 500 mL of MilliQ water was added to the dry-blend buffer, 
hnmunopure Immobilized Protein A was gently swirled to obtain an even suspension and 
0.4 mL of this suspension was placed into a Handee Spin Cup Column. The column was 
then placed into a Handee Microcentrifuge tube and centrifuged at 6,600 RPM in an 
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Eppendorf 5415R centrifuge for 1 minute. Flow-through was discarded and the gel 
column was washed twice by resuspending the gel in 0.4 mL Binding/Wash Buffer and 
centrifuging at 6,600 RPM for 1 minute, discarding the flow-through each time. The gel 
column was then placed into a new tube and -500 ug of primary polyclonal anti-Stxl8 
antibody prepared in 0.2 mL Binding/Wash Buffer was placed into the column. The tube 
was capped and placed on a rocker for 15 minutes to ensure binding of the antibody to 
the gel. The gel column was then centrifuged at 6,600 RPM for 1 minute and the flow-
through discarded. The gel column was then placed into a new tube and was washed 
three times by adding 0.5 mL Binding/Wash Buffer, inverting 5 times, centrifuging at 
6,600 RPM for 1 minute, and discarding the flow-through each time. 
Table 8: Reagent identity and composition used in immunoprecipitation 
experiments 
Reagent Composition 
ImmunoPure Immobilized Protein 1 mL of settled gel supplied as 50% slurry 
A Plus (PIERCE) 
Binding/Wash Buffer (PIERCE) 0.14M NaCl, 0.008M sodium phosphate, 0.002M 
potassium phosphate and 0.01M KC1, final pH = 7.4 
ImmunoPure IgG Elution Buffer Primary amine solution, pH 2.8 
(PIERCE) 
No-Weigh DSS (crosslinking Disuccinimidyl suberate 
agent) (PIERCE) 
Handee Spin Cup Columns Columns contain 0.45 urn cellulose acetate filters 
(PIERCE) 
For crosslinking of the antibody to the Protein A gel, the gel column was placed 
into a new tube and 0.4 mL of Binding/Wash Buffer was added. Eighty uL of dimethyl 
sulfoxide (DMSO) was added to a single tube of powdered disuccinimidyl suberate 
(DSS). Twenty five uL of this DSS/DMSO solution was then added to the gel column, 
which was then capped and placed on a rocker for 1 hour. The tube was then centrifuged 
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at 6,600 RPM for 1 minute and the flow-through was discarded. Five hundred uL of 
ImmunoPure Elution Buffer was added to the gel column, which was capped and inverted 
10 times. The column was then centrifuged at 6,600 RPM, the flow-through was 
discarded, and the process was repeated a further 4 times in order to quench the reaction 
and remove excess DSS and unbound antibody. The gel column was then washed twice 
with 500 uL aliquots of Binding/Wash Buffer in preparation for antigen 
immunoprecipitation. 
3.1.6 Immunoprecipitation of Stxl8-Ml antigen 
One hundred fifty uL (-75 ug) of purified Stxl8-Ml protein was diluted with 150 
uL of Binding/Wash Buffer and the solution was added to the gel column. The gel 
column was incubated with gentle mixing at room temperature for 1 hour and then 
centrifuged at 6,600 RPM for 1 minute, saving the flow-through for future analysis. The 
gel column was then placed into a new tube for the wash steps. Washing consisted of 
adding 500 uL Binding/Wash Buffer, capping and inverting the tube 10 times, and 
centrifuging it at 6,600 RPM for 1 minute. The flow-through was saved for each wash, 
and this wash was performed a total of three times. To elute target recombinant protein, 
190 uL Elution Buffer was added to the gel column, followed by capping and inverting it 
10 times, and centrifuging it at 6,600 RPM for 1 minute. Flow-through was saved as the 
elution fraction, and this elution step was performed a total of three times. To each 
elution fraction, 10 uL of 1M Tris pH 9.5 was immediately added to neutralize the acidic 
pH of the Elution Buffer, as suggested by the kit protocol. All saved samples (flow-
through, wash, and elution fractions) were then tested for endonucleolytic activity using 
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the Standard endonuclease assay, described below. Samples were also tested for 
presence of target recombinant protein via Western blot analysis. 
3.1.7 Gel filtration chromatography for purification of Stxl8-Ml 
In another attempt to obtain as pure a sample of Stxl8-Ml as possible, gel 
filtration (GF) chromatography purification was performed on a sample of Ni-NTA 
purified Stxl8-Ml. For this procedure, a HiLoad 16/60 Superdex 75 prep grade gel 
filtration column (Z) was used. This particular column uses a composite matrix of 
dextran and highly cross-linked agarose to separate proteins and peptides of a molecular 
weight range of 3-70 kDa at a flow rate of 0.3-1.6 mL/minute, although it performs best 
when separating proteins and peptides with a molecular weight range of 8-50 kDa (GE 
Healthcare). This gel filtration column was attached to an ISCO Model 160 Gradient 
Former and Foxy Jr. Fraction Collector (ISCO, Lincoln NB, USA) was used. To ensure 
the purity of the column, a series of cleaning steps were performed. First, 1 column 
volume (120 mL) of a 1 mg/mL pepsin, 0.1M acetic acid, 0.5M NaCl solution was run 
through the column and left overnight at room temperature to digest any residual protein 
that could have been bound in the column from prior use. The next day 1 column volume 
of 1M NaOH followed by 12 column volumes of TEA Binding/Wash buffer was run 
through the GF column to neutralize and wash out the pepsin-containing solution. Once 
the column was clean, the void volume (Vo) was determined by running 2 mL of a 1 
mg/mL Blue Dextran dye solution through the column, and observing at what volume the 
dye ran off the GF column. The GF column was then washed through with 20 column 
volumes of TEA Binding/Wash buffer in preparation for running a standard curve. 
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A four-protein standard set was prepared and run on the GF column; the standard 
set included bovine serum albumin (-66 kDa) (Sigma), ovalbumin (-49 kDa) (Sigma), 
bovine carbonic anhydrase (-29 kDa) (Sigma) and equine cytochrome C (-12.5 kDa) 
(Sigma). The volumes that these proteins eluted off the GF column at (see Table 9), as 
determined by an Isco UV-Vis spectrophotometer (Isco, Lincoln NE, USA) attached to 
the Foxy Jr. apparatus, were used to estimate the sizes of any proteins eluting off the 
column during the gel filtration of the Stxl8-Ml sample. 
Table 9: Gel filtration protein molecular weight standards and elution volume 
Protein standard (molecular weight) Elution volume 
Blue Dextran (2000 kDa) 47.5 mL (Void volume) 
Bovine serum albumin (66 kDa) 55.9 mL 
Ovalbumin (49 kDa) 62.0 mL 
Bovine carbonic anhydrase (29 kDa) 71.5 mL 
Equine cytochrome-C (12.5 kDa) 86.5 mL 
Approximately 2 mL of Ni-NTA purified and dialyzed Stxl 8-M1 was obtained 
and quantified for the gel filtration procedure. Quantity was determined by using a Bio-
Rad protein quantification assay (Bio-Rad, Hercules CA, USA) against a bovine serum 
albumin (New England Biolabs) standard curve. Protein concentration of the Stxl8-Ml 
sample was determined to be -0.4 ug/uL. To reduce the volume of the Stxl 8-M1 sample 
to 1 mL, for ease of loading onto the GF column, a 10 kDa molecular weight cutoff 
Nanosep protein concentrator (Pall Corporation, East Hills NY, USA) was used. Flow-
through from this Stxl8-Ml concentration step was saved for analysis along with the 
concentrated recombinant protein sample itself. 
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Gel filtration of the 1 mL, concentrated Stxl8-Ml sample was performed at a 
flow-rate of 1 mL/minute. UV-Vis spectrographs were used to determine approximate 
sizes of proteins eluting off the GF column at specific elution volumes using the standard 
curve derived above. Candidate GF UV-Vis peaks were analyzed via 15% SDS-PAGE 
visualized by silver staining. Candidate GF protein peaks were also tested for 
endonucleolytic activity using the Standard endonuclease assay, described below. 
Finally, candidate GF protein peaks were also analyzed via Western blot to determine 
whether or not candidate proteins were target Stxl8 recombinant protein. 
3.1.8 Standard endonuclease assay 
Once samples of recombinant protein were purified and dialyzed they could be 
tested for endonucleolytic activity. This simply required introducing the protein of 
interest to a sample of RNA and evaluating, using controls, whether or not the introduced 
protein sample was able to cleave mRNA. This was accomplished via radioactively 
labelling the 5'-end of the mRNA transcripts used in the assay; if mRNA in a given 
sample was cleaved, radioactively labelled mRNA transcripts would migrate faster 
during polyacrylamide gel electrophoresis than their uncleaved negative control 
counterparts. 
The Standard endonuclease assay used in the Lee lab is a procedure devised to 
test whether or not a given protein sample has the ability to cleave c-myc CRD RNA in 
vitro. To this end, a given amount/volume of protein sample is combined with 
Endonuclease assay cocktail solution such that the final concentrations of the components 
equal those shown for each component in Table 10. Differing amounts/volumes of 
protein can be combined with this reaction cocktail while maintaining component 
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concentrations simply by adjusting the amount of water used to make up the final volume 
(20 uL) of the reaction mixture. 
Table 10: Standard endonuclease assay cocktail components and reaction final 
concentrations 
Component Final Reaction Concentration 
lMTris-ClpH7.4 10 mM 
100 mM DTT 2 mM 
100 mM magnesium acetate 2 mM 
2.5 mM spermidine 0.1 mM 
RNasin (optional) 11.5 U 
Protein samples to be tested were combined with endonuclease assay cocktail in this way 
and kept on ice. Once all samples were prepared, 0.5-2 uL of y -P labeled c-myc CRD 
RNA probe were added to the reaction tubes and incubated at 37°C for 5 minutes. The 
reactions were stopped by the addition of 1 volume of RNA phenol loading dye. Five uL 
aliquots from each reaction were loaded onto a 5% denaturing polyacrylamide (29:1, 
acrylamide:N,N'-methylenebisacrylamide) gel containing 7M urea and run at 25 mA 
until the dye front approached the bottom of the gel plate. Gels were visualized using an 
autoradiograph generated by a Cyclone Storage Phosphor Screen System (Packard, 
Meriden CT, USA). Autoradiographs could be obtained for different time points (i.e. 3 
hours, overnight, etc.) simply by exposing the phosphor screen to the gel for the required 
length of time prior to imaging. 
3.2 Results and Discussion 
c-myc CRD RNA nucleotides 1705-1792 was chosen as the RNA to use for 
endonucleolytic tests simply because: (i) template was readily available due to other work 
being done in the Lee lab with c-myc CRD RNA, (ii) the aim of this investigation sought 
83 
to determine whether or not the Stxl8 recombinant proteins could cleave RNA, therefore 
specific RNA molecules were not required, (iii) the Lee lab is by now quite familiar with 
the sequence and structure of c-myc CRD RNA due to previous work done in the lab by 
Alaeddin Tafech (Tafech, 2006), and if Stxl8 recombinant proteins were to exhibit 
endonucleolytic activity using c-myc CRD RNA as the cleavage substrate would allow 
the determination of the prevalent cleavage sites and identification of the sequence and/or 
structure of the RNA molecule at those sites and (iv) most importantly, Stxl8 was 
identified as the responsible enzyme for cleaving c-myc CRD RNA in earlier experiments 
(Urquhart 2006). 
Digestion of pUC19-c-mvc-CRD plasmid was successful and c-myc CRD RNA 
was successfully transcribed from it, as shown in Figure 16. The single, sharp high 
molecular weight band in lane 2 of Figure 16 shows the linearized plasmid template; lane 
3 shows the successful elimination of this template via DNasel digestion. In vitro 
transcribed c-myc CRD RNA concentrations ranged from 3.5-4.5 ug/uL, and A26o:A28o 
ratios close to 2.0 indicated RNA purity was acceptable for continuation of preparation. 
Dephosphorylation and radioactive labelling of the c-myc CRD RNA proceeded without 
incident and initial scintillation counts on individual c-myc CRD RNA preparations 
ranged from 250,000-316,000 cpm. These initial preparations were deemed too 
radioactive for initial endonuclease assays, so they were diluted 1:4 in DEPC-treated 
water prior to use. 
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Figure 16: Generation of c-myc CRD RNA. 1% agarose gel depicting in vitro 
transcribed c-myc CRD RNA (lanes 2 and 3). Lane 2 shows the presence of the 
linearized pUC19-c-myc-CRD DNA template at a high molecular weight, whereas lane 3 
shows the absence of the DNA template after DNasel digestion. Estimated molecular 
weights are unlabeled due to improper running of the DNA ladder in lane 1. 
Purified Stxl8-Ml and Stxl8-M2 recombinant proteins were stored at -80°C in 
their denaturing 8M urea buffers until such time that the radioactive c-myc CRD RNA 
probe was ready for use. Recombinant proteins were dialyzed at this time and then used 
for standard endonuclease experiments within days. The initial endonuclease assay 
testing for activity of the Stxl8-Ml and -M2 recombinant proteins is shown in Figure 17. 
Negative controls are depicted in lanes 1 and 3-6; lane 1 is c-myc CRD RNA probe with 
no protein added, lanes 3 and 4 are different amounts (2.5 ug and 5.0 ug, respectively) of 
BSA, and lanes 5 and 6 are differing amounts (2.5 ug and 5.0 ug, respectively) of CRD-
BP [c-myc coding region determinant (CRD) binding protein (BP)], an 
endonucleolytically inactive c-myc CRD RNA binding protein generously donated by 
Dan Sparanese of the Lee lab (Sparanese, 2006). In lane 2 is 1 uL of partially purified rat 
liver endoribonuclease used as a positive control sample named 'post-hep', a generous 
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gift from Tavish Barnes of the Lee lab. Lanes 7 and 8 depict the effects of 4.0 ug Stx18-
Ml and Stxl 8-M2, respectively, on c-myc CRD RNA probe. Clear banding patterns can 
be seen for both Stx 18 recombinant protein samples that are significantly higher than any 
banding pattern seen in the negative controls. This suggests that both recombinant 
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Figure 17: Standard endonuclease assay of dialyzed Stxl8-Ml and Stxl8-M2. 
Autoradiograph depicting the endonucleolytic activities of truncated Stx 18 recombinant 
proteins on c-myc CRD RNA probe. Lanes 1 and 3-6 depict different negative controls in 
which no activity should be detected. Lane 2 is a positive control known to exhibit 
endonucleolytic activity, and lanes 7 and 8 are Stxl8-Ml and Stxl8-M2, respectively. 
protein samples do indeed exhibit endonucleolytic activity on c-myc CRD RNA. Stx 18-
Ml in particular showed a strong RNA cleaving activity when compared to Stxl 8-M2. 
This experiment was repeated at least twice (data not shown) in order to prove 
reproducibility of results. 
Endonucleolytic activity of Stxl8-Ml and Stxl8-M2, shown in the first 
experiment, could easily have been due to contamination of the containers and/or 
materials brought about by manipulation of the samples immediately prior to incubation. 
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If the activity observed was due to this sort of contamination by manipulation of samples, 
one would expect the activity to be concentration-independent. If, however, the activity 
seen was concentration-dependant, one could surmise that the activity was indeed due to 
the recombinant protein sample solution being added to the c-myc CRD RNA probe. An 
experiment in which the concentration-dependant effects of the Stxl8 truncated 
recombinant proteins is shown in Figure 18. Lanes 1 and 3-4 depict blank c-myc CRD 
RNA probe and differing concentrations of BSA, respectively, as negative controls. Lane 
2 displays cleavage of the c-myc CRD RNA probe as an effect of exposure to the post-
hep positive control protein sample. Lanes 5-7 and 8-10 exhibit, respectively, the results 
of different amounts of Stx 18-M1 and Stx 18-M2 recombinant protein. Cleavage of the c-
myc CRD RNA probe is readily apparent in all lanes where the RNA was exposed to 
Stx 18 recombinant protein. Interesting, however, is the apparent increase in cleavage 
fragment band intensity with increasing amounts of Stx 18-M 1. Stxl8-M2 shows a slight 
increase in RNA cleavage fragment band intensity as well, but not to the same degree as 
that of Stx 18-M 1. These results suggest that it is indeed a component of the protein 
sample solution that is responsible for the endonucleolytic cleavage seen thus far, as 
opposed to an introduced contaminant during reaction preparation. Furthermore the 
lessened intensity of Stxl8-M2 cleavage fragment bands, when compared to Stx 18-M 1, 
reinforce the results of the initial experiments in which Stxl8-M2 exhibited a much lesser 
degree of endonucleolytic activity than Stx 18-M 1. 
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Figure 18: Standard endonuclease assay of concentration-dependant effects of 
Stxl8-Ml and Stxl8-M2 samples. Autoradiograph depicting concentration-dependant 
effects of Stxl8-Ml and -M2 recombinant proteins. Lane 1 is a blank, showing c-myc 
CRD RNA probe by itself without being subjected to any form of protein. Lane 3 and 4 
are negative control depicting the effect of different amounts of BSA on c-myc CRD 
RNA; Lane 2 is post-hep positive control. Lanes 5-7 and 8-10 depict the effect on c-myc 
CRD RNA probe of increasing amounts of Stxl8-Ml and Stxl8-M2 recombinant protein, 
respectively. 
With the conclusion that Stxl8-Ml and Stxl8-M2 samples have endonucleolytic 
activity came the desire to pinpoint whether or not this activity was caused by the 
recombinant proteins themselves or some other co-purified contaminant protein and/or 
proteins residing in the samples as well. The first experiment, with an aim to identify 
whether or not the activity was caused by the Stxl8 truncated mutants, consisted of 
treating some samples with RNase-inhibitor (RNasin). RNasin serves to inhibit the 
nucleolytic activity of RNase A, RNase B, RNase C, and human placental RNase. 
Treating the endonucleolytic reactions with RNasin allowed the determination of whether 
88 
or not Stxl8 recombinant proteins were contaminated at any point during the purification 
process with any of these RNases, particularly RNase A which is commonly found in 
laboratory environments, notoriously robust, and difficult to eliminate (Raines, 1998). 
A standard endonuclease assay of the effect of RNasin on post-hep positive 
control and the Stxl8-M2 and -M2 recombinant proteins is shown in Figure 19. Lanes 1-
4 depict reactions carried out in the absence of RNasin, while lanes 5-8 depict reactions 
carried out in the presence of RNasin. Lanes 1 and 5 are negative controls of blank c-myc 
CRD RNA probe without being exposed to any protein samples. Lanes 2 and 6 show the 
cleavage fragment patterns of the post-hep positive control. Lane 6 shows that 11.5U 
RNasin had a significant deletory effect on the ability of the post-hep protein sample to 
cleave c-myc CRD RNA. While cleavage of RNA was still present in the RNasin treated 
sample, it was markedly reduced compared to that seen in the RNasin-untreated sample. 
This result served to confirm the validity of the premise behind using RNasin to 
determine whether or not the endonucleolytic activity could be attributed to RNase A or 
any of the other RNases inhibited by RNasin; the post-hep sample was not only a positive 
control in that it could cleave c-myc CRD RNA, but also in that it supported the theory 
that RNasin could be shown to significantly reduce the endonucleolytic activity of an 
RNase-containing protein sample. In contrast, the lanes in Figure 19 depicting the 
activity of the truncated Stxl8 recombinant proteins (lanes 3/7 for Stxl8-Ml and lanes 
4/8 for Stxl8-M2) show no significant reduction in endonucleolytic activity. The very 
slight reduction in activity observed has been deemed insignificant because, when 
compared to the amount of reduction observed in the positive control (lanes 1 and 5), if 
the activity seen in the Stxl8 recombinant mutant lanes was due to RNase contamination, 
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the activity should have been completely abolished by treating the Stxl8 recombinant 
protein samples with the same amount of RNasin that the positive control was treated 
with. This suggests that the activity of these samples is most likely not due to 
contamination with RNase A or any other of the RNases inhibited by RNasin. 
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Figure 19: Standard endonuclease assay of RNase-inhibitor (RNasin) effect on 
activity of post-hep positive control, Stxl8-Ml, and Stxl8-M2. Autoradiograph 
depicting effects of 11.5U RNasin (See Table 3.3) on endonucleolytically active samples. 
Lanes 1 and 5 are blank c-myc CRD RNA probe without exposure to protein samples. 
Lanes 2 and 6 are post-hep positive control, while lanes 3-4 and 7-8 are 1.0 ug each of 
Stxl8-Ml and Stxl8-M2, respectively. Lanes 1-4 depict results without RNasin 
treatment and lanes 5-8 depict results with RNasin treatment. 
Once activity of the recombinant Stxl 8 protein samples was decided to most 
likely not be due to RNase A contamination, two attempts were made to fully purify 
Stxl8-Ml via immunoprecipitation experiments. An anti-Stxl8 polyclonal antibody was 
used as the primary antibody for binding and purifying Stxl8-Ml with a Pierce Seize X 
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Protein A Immunoprecipitation kit. Preload, flow-through, wash, and elution fractions 
from the immunoprecipitation (IP) experiments were all kept and analyzed by both the 
standard endonuclease assay (for endonucleolytic activity) and Western blotting (for 
presence of recombinant Stxl 8-M1 protein). Results of the first IP experiment (DM) are 
shown in Figure 20. 
The standard endonuclease assay performed on the DM fractions is shown in Figure 20A. 
Lane 1, in which blank RNA is loaded, shows a fragmentation pattern indicative that the 
c-myc CRD RNA probe had degraded a certain amount. Stxl8-M1, in lane 2, was used 
as a positive control and continued to exhibit its endonucleolytic activity previously 
identified. All of the IP-1 Wash fractions (lanes 4-7) and IP-1 Elution fractions (lanes 8-
11) show no signs of endonucleolytic activity when compared to the fragment band 
pattern of the c-myc CRD RNA blank; the patterns seen for these samples are merely due 
to background decay. A sample of the IP-1 column flow-through in lane 3, however, 
exhibited a significant amount of endonucleolytic activity. This result was expected and 
can be attributed to one of two reasons. First, if endonucleolytic activity is due to Stxl 8-
Ml, some of the recombinant protein invariably would not have bound to the column and 
would have been present in the flow-through fraction. However, the second reason is that 
the protein responsible for the activity may not be the Stxl8 recombinant protein at all, in 
which case it would be expected to not bind to the IP column and endonucleolytic 
activity would be seen in the flow-through fraction. 
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Figure 20: Stxl8-Ml immunoprecipitation experiment 1. Results depicting 
endonucleolytic activity and presence of Stxl8-Ml in fractions of Stxl8-Ml 
immunoprecipitation (IP) experiment 1 (IP-1). (A) Autoradiograph depicting 
endonucleolytic activity of Stxl8-Ml IP-1 fractions. Lane 1 is negative control (blank), 
lane 2 is positive control (1.5 ug of Stxl8-Ml preload) and lane 3 is IP-1 column flow-
through. Lanes 4-7 are increasing concentrations of the first and last IP-1 Wash fractions, 
and lanes 8-11 are increasing concentrations of the first and last IP-1 Elution fractions. 
(B) Western blot indicating presence of Stxl8-Ml in various IP-1 fractions as detected 
by Stxl8 primary polyclonal antibody. 
Figure 20B shows the results of a Western blot analysis of the IP-1 fractions. 
Lane 1 is the Rainbow marker used for protein molecular weight estimation, lane 2 is the 
Stxl8-Ml protein sample prior to loading on the IP column, and lane 3 is the flow-
through from the IP column. Lanes 4-6 and 7-9 are samples of each of the three Wash 
and Elution fractions, respectively. The intense -38 kDa band representing Stxl8-Ml is 
clearly visible in the pre-load sample (lane 2), although smaller molecular weight 
degradation fragments are visible as well. Interesting, however, is the detection by anti-
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Stxl8 antibody of much larger molecular weight protein in the flow-through fraction 
(lane 3) and the Elution 1 fraction (lane 7). As discussed in Chapter 2, the anti-Stxl8 
antibody was generated using a 15 amino acid residue polypeptide near the N-terminus of 
the Stxl 8 protein as the epitope. Therefore, the flow-through fraction and Elution 
fraction 1 appear to contain some form of recombinant Stxl 8 protein, although why they 
are appearing at such a high molecular weight is unclear, and possible reasons will be 
discussed in Chapter 4. Despite the unusual apparent size of the recombinant Stxl8-Ml 
protein detected in the Western analysis, it can be said that the first IP experiment was a 
success; target Stxl8-Ml recombinant protein was detected in both the flow-through and 
the first Elution fraction, as would be expected. Unfortunately, this experiment led to the 
first indication that Stxl8-Ml may not be responsible for the endonucleolytic activity 
seen previously, as while activity was seen for the flow-through fraction there was none 
seen for Elution fraction 1. 
A colleague working in the Lee lab demonstrated success with IP experiments 
using a slightly modified protocol from the one provided with the Pierce Seize X Protein 
A Immunoprecipitation Kit. In this modified protocol, the step quenching the DSS 
crosslinking reaction with ImmunoPure Elution Buffer is replaced with simply washing 
the column three times with Binding/Wash Buffer. The purpose of this change was to 
eliminate a step in which the primary antibody is exposed to the low denaturing pH (pH 
2.8) of the ImmunoPure Elution Buffer before it is used to bind recombinant Stxl8 
antigen, even though the original Pierce Seize X Protein A Immunoprecipitation Kit 
protocol states that short-term exposure should not effect the efficacy of the IP 
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experiment. Other than this single change in the protocol, the second IP experiment (IP-
2) was performed identically to IP-1. Results of IP-2 are shown in Figure 21. 
Jr 
+ controls 
I 1 
^ y \ y "5 
• 
^ w *KKt 
"V > • "5 "J *3 r> <7 -3 
I f f * * 
• - * 
ft. 
s'&jrjfSj&P' 
kDa 
^v <^v ^  ^  / / ^ .'V 
1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 
Figure 21: Stxl8-Ml immunoprecipitation experiment 2. . Results depicting 
endonucleolytic activity and presence of Stxl8-Ml in fractions of Stxl8-Ml IP 
experiment 2 (IP-2). (A) Autoradiograph depicting endonucleolytic activity of Stxl8-Ml 
IP-2 fractions. Lanes 1-2 are negative control (blank), lanes 3-5 are positive controls 
(post-hep, affi, and GF samples) and lanes 6 and 7 are Stxl8-Ml preload and Stxl8-Ml 
preload mixed 1:1 with IP binding/wash buffer, respectively. Lane 8 is IP-2 column 
flow-through. Lane 9 is IP-2 Wash fraction 1 and lane 10 is a 1:1 mixture of IP-2 Wash 
fractions 2 and 3. Lanes 11-13 are Elution fractions 1-3. (B) Western blot indicating 
presence of Stxl8-Ml in various IP-2 fractions as detected by Stxl8 primary polyclonal 
antibody. 
The standard endonuclease assay performed on the IP-2 fractions is shown in 
Figure 21 A. Lanes 1 and 2 are c-myc CRD RNA blanks run in duplicate. Lanes 3-5 are 
positive controls: lane 3 is post-hep, and Affi (lane 4) and GF (lane 5) are partially 
purified rat liver endonuclease from Tavish Barnes (Barnes, 2007). Blanks and positive 
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controls all behaved as expected; no cleavage fragment patterns are detectable in the 
blanks, whereas all three positive controls exhibited a large degree of endonucleolytic 
activity. Lanes 6 and 7 are both 1.5 jag Stxl8-Ml, but lane 7 is a sample in which this 
amount of recombinant protein was diluted 1:1 with the IP Binding/Wash Buffer and 
incubated at room temperature for 0.5 hours; the intent of this treatment was to determine 
whether or not the IP Binding/Wash Buffer somehow eliminated the endonucleolytic 
activity detected in the samples previously. As can be seen in lanes 6 and 7, the buffer 
has no effect at all on the endonucleolytic activity of the samples. Lane 8 is a 5 uL 
sample of the IP-2 flow-through, and exhibits a large degree of endonucleolytic activity; 
this result is consistent with the result of IP-1 in that this flow-through still has 
endonucleolytic activity. It is interesting to note that the cleavage pattern seen here is 
quite different from the cleavage patterns seen for Stxl8-Ml in lanes 6 and 7. Lane 9 
exhibits endonucleolytic activity as well, with the same cleavage pattern as seen in lane 8, 
and it is a 5 uL sample of the IP-2 Wash fraction 1. This result is interesting in that it 
was not seen in the first IP experiment. Lanes 10-13 are the final IP-2 wash fractions 
combined and the three individual IP-2 Elution fractions, respectively, and none of these 
exhibited any endonucleolytic activity. 
Figure 21B depicts the result of a Western blot analysis of the IP-2 fractions with 
the anti-Stxl8 primary polyclonal antibody. Lane 1 is the Rainbow marker used for 
protein molecular weight estimation, lane 2 is the Stxl8-Ml protein sample prior to 
loading on the IP column, and lane 3 is the flow-through from the IP column. Like IP-1, 
a much higher molecular weight band than that found in the preload Stxl8-Ml sample is 
detected by the anti-Stxl8 primary antibody in the flow-through fraction. However, in 
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this experiment no band whatsoever was detected in any of the Elution fractions, unlike 
IP-1. 
When compared to IP-1, the results of IP-2 confirm the findings that 
endonucleolytic activity is present in the preload Stxl8-Ml sample and in the flow-
through fraction upon loading the sample onto the IP column. Endonucleolytic activity 
was not observed in elution fractions, however, and the fact that anti-Stxl8 antibody 
detected protein in one of the elution fractions that exhibited no endonucleolytic activity 
suggests that Stxl8-Ml is most likely not the protein responsible for the endonuclease 
activity. The evidence provided by these IP experiments remains inconclusive, however, 
as the bands that anti-Stxl8 antibody detected in both flow-through and Elution fractions 
were of much higher molecular weight than that seen for the Stxl 8-M1 protein in the 
preload samples, which corresponds to the recombinant protein's expected molecular 
weight of -38 kDa. This disparity in molecular weights will be discussed in Chapter 4. 
One hypothesis for the disparity in the apparent molecular weights of the proteins 
detected by the anti-Stxl8 antibody in the two IP experiments was that the anti-Stxl8 
primary antibody bound to the column may have been leaching from the column, and 
therefore the high molecular weight bands detected in the IP experiments would be false-
positives for Stxl8-Ml protein. A Western blot experiment was set up in order to 
determine whether or not antibody leaching was the cause of the high molecular weight 
bands. 15% SDS-PAGE gels were run in duplicate with a set of samples including 
Stxl8-Ml preload, IP-1 Elution fraction 1, IP-1 flow-through fraction, Stxl8-Ml diluted 
1:1 in IP Binding/Wash buffer, boiled IP-1 column beads, and pure anti-Stxl8 polyclonal 
antibody. The proteins on the duplicate gels were transferred to nitrocellulose membrane 
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and processed normally for a Western blot as described in Chapter 2, with one exception: 
for one of the blots, the 1 hour anti-Stxl8 primary antibody incubation was eliminated. 
In this way, anti-Stxl8 antibody leaching from the IP column could be detected if high 
molecular weight bands were detected on the blot in which no primary antibody 
incubation was performed. The results of this Western blot antibody leaching experiment 
are shown in Figure 22. 
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Figure 22: Immunoprecipitation antibody leaching experiment. Primary polyclonal 
anti-Stxl 8 antibody leaching from the IP column could have been the cause of the high 
molecular weight protein bands detected in IP-1 and IP-2. Lane assignments in both 
blots are identical: lane 1 is Rainbow marker, lane 2 is 10 uL Stxl8-Ml, lane 3 is 10 pL 
IP-1 Elution 1, lane 4 is 10 uL IP-1 flow-through, lane 5 is 15 uL 1:1 Stxl8-Ml: IP 
Binding/Wash buffer, lane 6 is 10 uL of boiled IP-1 column bead solution, and lane 7 is 
10 uL pure anti-Stxl8 primary polyclonal antibody. (A) Western blot of IP fractions in 
which the primary antibody incubation step was eliminated. (B) Western blot of IP 
fractions following normal Western blot procedures. 
Figure 22A depicts a Western blot analysis of IP fractions with the elimination of 
the primary anti-Stxl8 antibody incubation step. Anti-Stxl8 primary polyclonal antibody 
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was run in lane 7, and it was successfully detected by incubating the blot with only anti-
rabbit secondary antibody. If any of the anti-Stxl 8 primary antibody had been leaching 
from the IP column, one would expect similar bands to the one detected in lane 7 to 
appear in the IP-1 Elution fraction (lane 3), the IP-1 flow-through fraction (lane 4), and 
perhaps the boiled IP column beads (lane 6). The fact that no bands were detected in any 
of these lanes suggests that there was in fact no primary anti-Stxl8 antibody leaching 
from the IP column, and therefore this is not the cause of the apparent high molecular 
weight bands seen in the Western blot analyses of the IP experiments. 
Figure 22B depicts a duplicate Western blot performed including the normal 
primary anti-Stxl8 primary antibody incubation step. Anti-Stxl8 primary antibody is 
successfully detected once again in lane 7, and Stxl8-Ml protein of the appropriate 
molecular weight (-38 kDa) is detected in the Stxl8-Ml sample (lane 2), the 1:1 Stxl8-
M1:IP Bind/Wash buffer mixture (lane 5), and perhaps also in the IP-1 flow-through 
fraction (lane 4). It is interesting to note here that that appropriately-sized Stxl8-Ml had 
not been detected in the IP-1 flow-through before this, and furthermore for some reason 
the high-molecular weight band detected in the Elution 1 fraction of the Western blot 
analysis of the IP-1 experiment was not detected here. Unfortunately, at the conclusion 
of this experiment there was not enough of the IP fractions left to perform additional 
experiments on, and a decision was made to attempt to further purify Stxl8-Ml from the 
Stxl8-Ml protein sample by a different means: gel filtration chromatography. 
A GE Healthcare HiLoad 16/60 Superdex 75 prep grade gel filtration column was 
used to separate 1 mL of concentrated Stxl8-Ml recombinant protein sample into its 
constituent components. Void volume was found to be 47.5 mL by running a Blue 
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Dextran solution through the column prior to running the Stxl8-Ml sample. A protein 
molecular weight standard set was also run (see Table 9) prior to loading the Stxl8-Ml 
sample so that the molecular weights of proteins eluting off the gel filtration column 
could be estimated. Upon gel filtration of the concentrated Stxl8-Ml sample, the UV-
Vis spectrophotometer attached to the filtration apparatus detected only two peaks eluting 
off of the column: one from 48-52 mL and one from 105-114 mL (data not shown). Five 
uL aliquots of GF fractions spanning these regions were loaded onto a 15% SDS-PAGE 
gel along with 1 uL aliquots of the original Stxl8-Ml sample and the Nanosep 
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Figure 23: Silver-stained 15% SDS-PAGE analysis of Stxl8-Ml gel filtration peaks. 
Gel filtration of a concentrated Stxl8-Ml recombinant protein sample resulted in UV-
Vis-detected protein peaks eluting at 48-52 mLs and 105-114 mLs; samples from these 
elution peaks are analyzed here. Lane 1 is molecular weight marker, lane 2 is 1 |iL 
Stxl8-Ml sample, and lane 3 is 1 uL of Nanosep concentrated (GF-preload) Stxl8-Ml 
sample. Lanes 3-6 are 5 uL aliquots from GF fractions 48, 49, and 51, respectively, 
spanning the first GF elution peak. Lanes 7-10 are 5 uL aliquots from GF fractions 106, 
109, 111, and 113, respectively, spanning the second GF elution peak. 
(for gel filtration) Stxl8-Ml sample. This gel was visualized by silver-staining and is 
shown in Figure 23. Lane 1 is protein molecular weight marker, lane 2 isl uL of 
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Stxl8-Ml sample, and lane 3 is 1 |aLof Nanosep concentrated Stxl8-Ml sample. As 
expected, an intense -38 kDa band representing recombinant Stxl8-Ml is visible in lanes 
2 and 3. Lanes 4-6 represent 5 uL aliquots of GF fractions 48, 49, and 51 respectively; 
these fractions span the first observed protein peak eluting off of the GF column. Lanes 
7-10 represent GF fractions that span where the second protein peak eluted off of the 
column. Protein is visible in only one fraction via 15% SDS-PAGE visualized by silver 
staining: GF fraction 49 of the first eluted protein peak (lane 5). The protein band has an 
apparent molecular weight of -38 kDa, and appears to be Stxl8-Ml based on this 
molecular weight determination. It is interesting to note that this protein eluted off of the 
column at near the void volume of the column, and this particular GF column is designed 
to separate proteins in the 3-70 kDa molecular weight range. For the protein to elute off 
of the GF column at this volume it would have to have a molecular weight equal to or 
greater than 70 kDa. Furthermore, no protein is visible for the second detected protein 
peak. This is probably due to dilution effects and protein size; the smallest protein 
standard, equine cytochrome-C, had a molecular weight of 12.5 kDa and eluted off of the 
column at 86.5 mL, and as such any proteins and/or peptides eluting off of the column at 
the second peak, 105-114 mL, would be very small (most likely less than 5 kDa in size). 
In case the reliability of the UV-Vis detector of the gel filtration apparatus was in 
question, a broad-spectrum endonuclease assay was run on the entire range of gel 
filtration fractions collected at specific intervals. Fractions spanning the first detected 
peak were all tested for endonucleolytic activity (GF fractions 48-50) and fractions 
spanning the second peak and the end of the gel filtration were tested after every other 
fraction (GF fractions of even numbers fraction 110 to fraction 130); all other GF 
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fractions were tested for activity every third fraction from GF fraction 53 to fraction 107). 
The results of this standard endonuclease assay are shown in Figure 24. Lanes 1 and 38 
are blank c-myc CRD RNA and lanes 2 and 39 are post-hep positive control, seen here to 
cleave the RNA probe to a large degree. Lane 3 is a 20 uL sample of the flow-through 
collected when the Stxl8-Ml sample was concentrated by a 10 kDa molecular weight 
cutoff Nanosep device (Pall). This lane exhibited a large degree of endonucleolytic 
activity, and this is interesting as there should be no protein above the size of 10 kDa in 
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Figure 24: Standard endonuclease assay of gel filtration chromatography fractions. 
Autoradiograph depicting possible endonucleolytic activity of GF fractions. Lanes 1 and 
38 are c-myc CRD RNA blanks as negative controls, and lanes 2 and 39 are post-hep 
positive controls. Lane 3 is a 20 uL aliquot of the saved Nanosep flow-through from the 
Stxl8-Ml concentration step. Lane 4 is a 1 uL aliquot of the Stxl8-Ml Nanosep 
concentrated sample. Lanes 5-37 are 20 uL aliquots from a series of GF fractions 
spanning the full range of the GF fractions collected; specific fraction volumes tested are 
labeled above. 
this sample, and therefore there should be no Stxl8-Ml recombinant protein in it. Lane 4 
is a 1 uL sample of the Nanosep concentrated Stxl8-Ml that was loaded onto the GF 
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column, and also displays a degree of endonucleolytic activity. All other lanes (lanes 5-
37) represent 20 |iL samples of the range of GF fractions tested, including those spanning 
the two detected protein peaks, and not one among them display any signs of 
endonucleolytic activity when compared to the c-myc CRD RNA blank. These results, 
by themselves, suggest that the -38 kDa Stxl 8-M1 is not responsible for the 
endonucleolytic activity seen in the Stxl8-Ml protein sample. 
To confirm the results from the assay run on the GF fractions, a separate standard 
endonuclease assay was performed, and the results are shown in Figure 25. Lanes 1 and 
2 are the negative and positive controls, respectively, and as always the post-hep displays 
a high degree of c-myc CRD RNA cleavage. Lanes 3-5 are increasing concentrations of 
the flow-through from the concentration of the Stxl8-Ml protein sample. Interestingly, 
the 1 uL (lane 3) and 5 uL (lane 4) samples do not show any signs of endonucleolytic 
activity, while the 20 uL (lane 5) sample does, which corroborates the results found in the 
earlier assay of the GF fractions (see Figure 24). Lanes 6 and 7 are 1 uL and 2 uL, 
respectively, of the Nanosep concentrated Stxl8-Ml sample and both show the 
characteristic endonucleolytic activity that is familiar for this particular sample, although 
the 1 uL sample shows lessened activity due to the small size of the sample. Lanes 8 and 
9 are 1 uL and 2 uL, respectively, of the original un-concentrated Stxl8-Ml protein 
sample and also exhibit the same endonucleolytic activity as before (see Figure 17). 
Lane 10, exhibiting no endonucleolytic activity, is a 20 uL sample of the GF fraction 49, 
in which the ~38 kDa band was detected by SDS-PAGE analysis and silver-staining (see 
Figure 23). In order to be sure that lack of activity wasn't due to the 
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Figure 25: Standard endonuclease assay determining endonucleolytic activity of 
candidate Stxl8-Ml GF fractions and Stxl8-Ml NanoSep concentration fractions. 
Lane 1 is c-myc CRD RNA blank and lane 2 is post-hep positive control. Lanes 3-5 are 
increasing concentrations (1 uL, 2 |JL, and 5 uL, respectively) of the flow-through 
fraction from the concentration of the Stxl8-Ml protein sample with a Nanosep device. 
Lanes 6 and 7 are 1 uL and 2 uL, respectively, of the Nanosep concentrated Stxl8-Ml 
protein sample used for gel filtration. Lanes 8 and 9 are 1 |JL and 2 uL, respectively, of 
the original, un-concentrated Stxl8-Ml protein sample. Lane 10 is 20 uL of the GF 
fraction 49, and lanes 11 and 12 are 10 uL and 20 uL, respectively, of a GF fraction 49 
sample concentrated with a Nanosep device. 
inherently small concentration of the GF fraction 49, this sample was concentrated down 
to 1/10 of its original volume using a 10 kDa molecular weight cutoff Nanosep device 
(Pall). Lanes 11 and 12 are 10 uL and 20 uL, respectively, of this Nanosep concentrated 
GF fraction 49 sample. No endonucleolytic activity is seen for these samples and it 
would thus appear that this experiment reinforces the conclusions made of the results of 
the original assay of the GF fractions. 
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The final experiment in this investigation consisted of testing the flow-through of 
the Stxl8-Ml sample Nanosep concentration and the GF fraction 49 sample for presence 
of Stxl8-Ml. This was accomplished by performing a Western blot on these samples, 
and the results are shown in Figure 26. Lane 1 is the Rainbow marker, lane 2 is the 
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Figure 26: Western blot analysis of endonucleolytically active Stxl8-Ml and 
Nanosep fractions and endonucleolytically inactive GF fraction 49. Lane 1 is 
Rainbow marker. Lanes 2 and 3 are Stxl8-Ml protein and Stxl8-Ml protein 
concentrated with a Nanosep device, respectively. Lane 4 is the flow-through from the 
Nanosep concentration of the Stxl8-Ml protein sample. Lane 5 is GF fraction 49, in 
which an -38 kDa protein was visualized by silver-staining, and lane 6 is a GF fraction 
49 sample concentrated with a Nanosep device. 
original Stxl8-Ml sample, and lane 3 is the Stxl8-Ml Nanosep concentrated sample. As 
always, Stxl8-Ml is readily detected by the anti-Stxl8 antibody as a protein with a 
molecular weight of ~38 kDa, as expected. Lane 4 is the flow-through from the Nanosep 
concentration, and no Stxl 8-M1 was detected. Lanes 5 and 6 are both samples of the GF 
fraction 49, and it is interesting to see that no Stxl8-Ml is detected here either. These 
samples have an -38 kDa protein in them, as detected by silver-stained 15% SDS-PAGE 
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analysis (see Figure 23), and as Stxl8-Ml comprised the majority of the sample loaded 
onto the GF column, it was thought that the ~38 kDa band appearing in GF fraction 49 
(see Figure 23) was itself Stxl8-Ml. Due to the fact that Stxl8-Ml did comprise most of 
the protein loaded onto the GF column, it is still possible that the ~38 kDa protein 
detected in GF fraction 49 is Stxl8-Ml, but somehow the protein may have been altered 
in some way so as to prevent efficient binding of the anti-Stxl8 antibody to the protein. 
This will be discussed in more detail in Chapter 4. 
105 
Chapter 4 
General Discussion 
4.1 Overview 
Regulation of mRNA decay is now undisputed as a major control point in the 
regulation of gene expression. Furthermore, the initial control points of mRNA decay 
itself appear to be decapping, deadenylation, and endonucleolytic cleavage (Tourriere et 
al. 2002). To date, a number of endonuclease activities have been discovered in 
mammalian cells, including activity that involves the cleavage of such diverse mRNA 
transcripts as transferrin receptor, cytokine groa, albumin, IGFII, a-globin, and c-myc 
(Tourriere et al. 2002). 
C-myc is a proto-oncogene that encodes a transcription factor that, when 
deregulated, is prevalent in a large majority of human cancers (see Table 2). Studies 
involving the discovery of an endonucleolytic cleavage event of c-myc mRNA have led 
to the purification of an -35 kDa protein that was believed to be responsible for the 
endonucleolytic activity (Bergstrom et al. 2006). Digestion of this purified protein with 
trypsin, followed by MALDI mass spectroscopy analysis, revealed that four of the ~35 
kDa protein's tryptic peptides were a match for syntaxin 18 (Urquhart 2006). In addition, 
polyclonal primary antibody specific for Stxl8 confirmed the presence of Stxl8 in the 
partially purified enzyme samples (Urquhart 2006). 
Syntaxin 18 is a soluble N-ethylmaleimide sensitive factor (NSF) attachment 
protein (SNAP) receptor (SNARE) that has been shown to be involved in vesicular 
transport between the ER and Golgi apparatus, being most specifically localized to the 
ER membrane (Hatsuzawa et al. 2000). The findings by Bergstrom et al (2006) and 
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Urquhart (2006) are the first evidence ever reported that syntaxin 18, or any SNARE 
protein, may be involved in a cellular mRNA regulation processes mediated by 
endonucleolytic cleavage events. 
The purpose of this investigation was to confirm the endonucleolytic activity of 
syntaxin 18 by generating, purifying, and refolding recombinant forms of syntaxin 18 and 
its truncated mutants and testing them for endonucleolytic activity in vitro. If 
endonucleolytic activity was confirmed, this investigation was to seek out the amino acid 
residues responsible for this activity with the aim of potentially identifying a novel 
catalytic domain. Unfortunately, this work was found to support a hypothesis in which 
syntaxin 18 does not appear to have the ability to endonucleolytically cleave mRNA in 
vitro. 
4.2 Expression of recombinant Stxl8 truncated proteins 
In order to test the ability of Stxl8 to endonucleolytically cleave c-myc CRD 
RNA, a number of truncated Stxl8 proteins were generated (see Table 6). The 
generation and purification of full-length Stxl8 protein was attempted first, but it was 
assumed that this attempt would be unsuccessful due to Stxl8's transmembrane anchor. 
Indeed, the full-length Stxl8 protein failed to be expressed via IPTG induction of Stxl8-
FL-bearing expression plasmid in E. coli BL21 cells (see Figure 10A). It is believed that 
this failure to induce expression of the full-length Stxl8 protein was due to the 
transmembrane anchor incorporating the protein into host cell membranes and thereby 
exhibiting a toxic effect on the host bacterial cells; it has previously been described that 
transmembrane proteins can be difficult to express for this very reason (Selinsky 2003). 
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Previous characterization studies of Stxl8 actually used a recombinant form of 
the Stxl8 protein that lacked its transmembrane domain (Hatsuzawa et al. 2000). For this 
reason, the recombinant Stxl 8 truncated mutant that was of most interest in this 
investigation was Stxl8-Ml, as this first truncated form of the protein simply eliminated 
the transmembrane anchor. This protein should theoretically exhibit the same activities 
as its full-length precursor, having a fully intact N-terminal region and SNARE domain 
(see Table 6), albeit in a potentially soluble form. The successful IPTG-induced 
expression of Stxl8-Ml (shown in Figure 10B) provides evidence for the conclusion that 
it is the transmembrane anchor that was responsible for the failed expression of the full-
length Stxl8 protein. 
After successful expression of the Stxl8-Ml recombinant protein, expression 
experiments were carried out on the other three Stxl8 truncated mutants under 
investigation in this project. Stxl8-M2 and Stxl8-M4 were both successfully induced via 
IPTG, whereas Stxl8-M3 was not (see Figure 12). What's more, as described in section 
2.2, attempted induction of Stxl8-M3 actually had a highly deleterious effect on the host 
E. coli bacterial cells, with induced cultures experiencing cell death and exhibiting much 
lower cell densities than their uninduced cell culture counterparts of the same time points 
(data not shown). Indeed, this deletory effect was reproducible in every instance, 
including further induction experiments with different cell lines (E. coli BL21-pLysS and 
Rossetta2 strains) and different growth conditions (incubation at 4°C and at room 
temperature). An explanation for this phenomenon is difficult to elucidate. Could it be 
that Stxl8-M3 was able to interact with an endogenous E. coli protein that was essential 
to the bacteria's viability? Or was it that Stxl8-M3 was able to cleave bacterial host 
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RNA and thereby render the expressing cells unviable? An appropriate answer to these 
questions was not forthcoming, and further research on this particular phenomenon would 
be needed to truly define why Stxl8-M3 had this effect on the expressing E. coli cells. If 
expression and purification of Stxl8-M3 is desirable in future experiments, one might try 
using one of the Qiagen pQE-80L series of expression vectors and transforming it into E. 
coli Ml5 [pREP4] cells, as suggested for the attempted expression and purification of 
toxic proteins by Qiagen's high-level recombinant protein expression handbook (Qiagen 
2003). 
4.3 Purification of recombinant Stxl8 truncated proteins 
Once the Stxl8 recombinant proteins had been successfully expressed via small-
scale IPTG induction, it was imperative to determine the solubility of the Stxl8-Ml 
protein so that a purification scheme could be decided upon. The results of the solubility 
tests are shown in Figure 11 and indicated that Stxl8-Ml was expressed as an insoluble 
protein. It had been hoped that a significant amount of Stxl8-Ml would be present in the 
soluble phase in order to allow a native, non-denaturing purification scheme for the Stxl 8 
recombinant proteins, but the finding that Stxl8-Ml was actually insoluble despite 
lacking the transmembrane domain was not surprising; it had already been reported that 
Stxl8 recombinant protein lacking a transmembrane domain had to be purified from 
inclusion bodies using the strong denaturant guanidinium chloride (Hatsuzawa et al. 
2000). 
Following the determination of Stxl8-Ml solubility, a denaturing protocol in 
which expressed proteins were solubilized in 8M urea was used. 8M urea is not as strong 
a denaturant as guanidinium chloride, but has the significant advantage that protein 
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samples dissolved in 8M urea can be analyzed immediately via SDS-PAGE, whereas 
protein samples dissolved in guanidinium chloride must be specially treated to remove 
the guanidinium chloride prior to SDS-PAGE analysis. Despite its weaker denaturant 
properties, the success of 8M urea in solubilizing Stxl8 recombinant proteins is evident 
in the successful purifications of the proteins, shown in Figures 15 and 17. 
Figure 13 shows the successful purification of Stxl 8 recombinant proteins 
expressed and purified from pHTT7K expression vector, whereas Figure 15 shows the 
purification of Stxl8 recombinant proteins expressed and purified from pET28a 
expression vector. As discussed in Section 2.2, this change of expression vector was due 
to the sudden failure of pHTT7K construct to successfully express high levels of 
recombinant protein upon IPTG induction. This phenomenon was perplexing, as it 
occurred for both Stxl8-Ml and Stxl8-M2 containing pHTT7K plasmids; numerous 
large-scale inductions were carried out in order to re-express and purify Stxl8-Ml and 
Stxl 8-M2 recombinant protein with no success. The cause of the problem remains 
unknown, but the decision to religate the Stxl8-Ml and Stxl8-M2 sequences into the 
new pET28a expression vector eliminated the problem as Stxl8 recombinant proteins 
were immediately expressed and purified from this vector upon IPTG induction. 
After successful purification of the Stxl8 recombinant proteins, a Western blot 
using primary Stxl 8 polyclonal antibody was performed on each of them in order to 
confirm their identity (see section 2.1.13 and Figure 14). This analysis revealed that 
Stxl8-Ml, -M2, and -M4 were all successfully purified as expected (Figures 15 and 17); 
however, it is interesting to note that there appears to be a diffuse higher molecular 
weight band than expected in the Stxl8-M4 sample (Figure 14). The projected size of 
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Stxl8-M4 was ~7 kDa (see Table 6) and the size of this higher molecular weight band 
(-12-14 kDa) suggests that it may be a homodimer of the Stxl8-M4 protein. This finding 
is of interest because the sample was an 8M urea, pH 4.5 elution fraction from the 
denaturing purification process; if this band is indeed a homodimer of Stxl8-M4, the 
interaction must be very strong in order to be both 8M urea and SDS-resistant. 
Stxl8-M4 consists solely of the first 46 residues of the N-terminal portion of the 
Stxl8 protein. It has previously been reported that N-terminal domains of some syntaxin 
proteins have the ability to bind internally to their own C-terminal SNARE domains, 
causing the syntaxin to adopt a 'closed' conformation that may have regulatory 
significance in the role syntaxins play in membrane fusion (Dietrich et al. 2003). This 
activity of the N-terminal domain has not been described for Stxl8; indeed, a different 
interaction has been described for the closest Stxl8 homolog, the yeast syntaxin Ufelp. 
Ufelp lacking its transmembrane domain has been demonstrated to form higher-order 
multimers with itself (Patel et al. 1998). It is believed that this ability of Ufelp to form 
homomultimers with itself is indicative of the mechanism by which Ufelp participates in 
homotypic ER membrane fusion (Patel et al. 1998). Despite being Ufelp's closest 
homolog, Stxl8 has not yet been definitively determined to participate in homotypic ER 
membrane fusion processes in mammalian cells (Teng et al. 2001); however, if Stxl8 can 
be shown to be able to form multimers with itself, as suggested here, it may lend 
evidence to the hypothesis that Stxl8 plays a similar role in mammalian cells to Ufelp's 
role in yeast. 
I l l 
4.4 Testing the ability of recombinant Stxl8 truncated proteins to 
cleave c-myc CRD RNA 
After successful generation of 5'-radiolabeled c-myc CRD RNA and dialysis of 
Stxl8-Ml and Stxl8-M2, initial endoribonuclease assays were performed (see Figure 
17). In these initial assays, when compared to positive and negative controls, it appeared 
that Stxl 8-M1 and Stxl8-M2 both exhibited a degree of endonucleolytic activity, 
particularly Stxl8-Ml. This activity appeared to confirm the previously reported 
endonucleolytic activity of Stxl8 by Urquhart (Urquhart 2005) that led to this 
investigation of the catalytic domain of Stxl8. 
As this investigation progressed, more indirect support of the initial findings by 
Urquhart came about: it was determined that the endonucleolytic activity of the Stxl 8-
Ml protein sample occurred in a concentration-dependant manner (Figure 18) and the 
protein responsible also appeared to be RNasin-resistant (Figure 19), which would be 
expected if the purified native protein was indeed Stxl8. 
4.4.1 Immunoprecipitation of Stxl8-Ml 
The first doubt that Stxl8-Ml had the ability to cleave c-myc CRD RNA came 
from the analysis of the results of the immunoprecipitation (IP) experiments (see Figures 
22 and 23). During the course of these experiments, Stxl8-Ml was successfully 
immunoprecipitated by anti-Stxl8 primary polyclonal antibody, and yet it did not exhibit 
any endonucleolytic activity (Figure 20). The pre-loaded Stxl8-Ml sample and the flow-
through from the IP column did exhibit endonucleolytic activity, however, suggesting for 
the first time that a different, contaminating component of the Stxl8-Ml sample was 
most likely responsible. 
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It must be noted here, also, that doubt in Stxl8's ability to cleave mRNA also 
came about from the observation of how much Stxl8-Ml sample was required to observe 
a moderate amount of endonucleolytic activity. In this investigation, 1-2 ug of protein 
were typically used for endonuclease assay experiments, and recent work in the Lee lab 
with a known protein that has a newly discovered endonuclease activity, APE1, shows 
that a similar level of activity as observed for Stxl8-Ml can be achieved with APE1 with 
10-20 fold less purified recombinant protein (-0.1 ug) (Barnes 2007), suggesting that the 
Stxl8-Ml sample activity is most likely not due to Stxl8-Ml itself, but rather some 
unidentified contaminating protein. Indeed, APE1 is not the only characterized 
endoribonuclease shown to exhibit similar endonucleolytic activity as that seen for 
Stxl8-Ml but with much less protein. In the characterization experiments for Irelp and 
ARD1, a similar amount of radioactively labeled RNA was shown to be cleaved by 0.5 
ug protein in a reaction volume of 100 uL (Tirasophon et al. 2000) and 0.5 ug in a 
reaction volume of 20 uL (Claverie-Martin et al. 1997), respectively. 
It is interesting also to discuss here the fact that some inexplicable data came out 
of the IP experiments. First, for an unknown reason, the Stxl 8-M1 proteins appeared to 
form high molecular weight aggregates with each other after passing through the IP 
column, as observed in the Western blot portions of the IP experiments (see Figures 22B 
and 23B). It was first thought that these high molecular weight bands were due to 
primary polyclonal anti-Stxl8 antibody leaching from the IP column, but this hypothesis 
was refuted by the experiment the results of which are shown in Figure 22. As SNARE 
proteins are known to form SDS-resistant coiled-coil complexes with each other (Chen et 
al. 2001), and Ufelp has been demonstrated to form higher-order homomultimers (Patel 
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et al. 1998), it could be that the action of passing through the IP column initiated the 
aggregation of Stxl8-Ml with each other to form the high molecular weight bands 
observed. Unfortunately, if this is the case, the aggregation would undoubtedly interfere 
with Stxl8's ability to cleave c-myc CRD RNA, if it does have the ability to do so; this 
could potentially be the reason why no activity was seen in the IP elution fraction 
containing recombinant Stxl8 (Figure 20). 
The other inexplicable result to come from the IP experimental results was the 
sudden change of the endonucleolytic cleavage fragment pattern between 
endonucleolytically-active samples that had and had not passed through the IP column 
(Figure 21). This change in cleavage fragment pattern was observed only in the second 
IP experiment, which failed to successfully immunoprecipitate Stxl8-Ml, and the reason 
for this change is unknown. 
4.4.2 Gel filtration chromatography of Stxl8-Ml 
In a final attempt to obtain as pure a sample of Stxl8-Ml as possible for 
endonuclease assay experiments, a gel filtration (GF) of a concentrated Stxl8-Ml protein 
sample was performed (see section 3.1.7). Approximately 2 mL of purified recombinant 
Stxl8-Ml was concentrated down to 1 mL using a 10,000 MWCO NanoSep centrifugal 
device; the membrane of this device would allow liquid and anything with a molecular 
weight smaller than 10 kDa to easily pass through, keeping the -38 kDa Stxl8-Ml 
protein and other proteins >10 kDa in the sample chamber. An -38 kDa protein band 
eluted off of the GF column at 48-50 mL, which approximately coincided with the void 
volume (Vo) of the column (see section 3.1.7 and Figure 23). Based on the technical 
specifications of the GF column used (Amersham Biosciences 2001), any protein eluting 
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off at that volume would either have a molecular weight of >70 kDa, or have a non-
globular tertiary structure that results in the migration of the protein through the GF 
matrix in a non-conventional manner. This finding that Stxl8-Ml eluted at the Vo could 
be taken as evidence that Stxl8 without its transmembrane domain, like Ufelp, has the 
ability to form higher-order multimers with itself; if the Stxl8-Ml protein was present in 
solution as free monomer it should have eluted off the GF column at -67 mL based on its 
size of -38 kDa (see Table 9). 
Unfortunately, the gel filtration experiment resulted in convincing evidence that 
Stxl8-Ml does not have the ability to cleave c-myc CRD RNA. A set of fractions from 
the GF column was tested for endonucleolytic activity (including fraction 49, containing 
the -38 kDa protein) and none exhibited any endonucleolytic activity whatsoever (Figure 
24). The interesting finding, though, was that the flow-through from the concentration of 
the Stxl8-ml sample with the NanoSep device prior to the gel filtration exhibited a large 
degree of endonucleolytic activity. Due to the nature of the NanoSep device and the 10 
kDa molecular weight cutoff of its membrane, this flow-through sample should only have 
had very small proteins and/or protein fragments in it, and the fact that it exhibited 
endonucleolytic activity provided clear evidence that the activity of the Stxl8-Ml protein 
sample is most likely due to a small contaminant protein. This hypothesis was further 
supported when concentration effects of various protein samples (including the Nanosep 
flow-through, original Stxl8-Ml sample, and the -38 kDa protein-containing GF fraction 
49) were tested for endonucleolytic activity (Figure 25). 
The final experiment that allowed the conclusion that Stxl8-Ml is most likely not 
responsible for any endonucleolytic activity of the Stxl8-Ml sample was a Western blot 
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performed with the anti-Stxl8 primary polyclonal antibody. The purpose of this blot was 
to determine whether or not there was any detectable Stxl8 recombinant protein in the 
NanoSep flow-through fraction (Figure 26). The results of this Western blot showed 
definitively that there was no detectable Stxl8 recombinant protein in the NanoSep flow-
through fraction, and this was the first time that it could be said that a sample lacking any 
recombinant Stxl8 protein had endonucleolytic activity, suggesting that some protein 
other than a recombinant Stxl 8 protein was responsible. The final blot also sought to 
definitively show a sample that did contain recombinant Stxl8 protein but lacked 
endonucleolytic activity: the GF fraction 49 containing the -38 kDa protein (see Figures 
25 and 28). As Stxl8-Ml was by far the most prevalent protein in the pre-load 
concentrated Stxl8-Ml sample, it was assumed that the -38 kDa band eluting at 49 mL 
in the GF experiment could be none other than Stxl8-M1. Surprisingly, however, the 
final Western blot failed to detect a Stxl8 recombinant protein in this GF fraction (Figure 
26). Again, since Stxl8-Ml was by far the most prevalent protein in the sample, it is still 
believed that the -38 kDa band seen in GF fraction 49 is Stxl8-Ml, but why the primary 
Stxl8 polyclonal antibody failed to detect it as such is unknown; perhaps the GF fraction 
49 protein sample was too dilute for effective Western blot analysis. In the future, if it is 
imperative that this protein be identified, MALDI-MS analysis can be used. Fortunately, 
however, the other results were sufficient evidence for the conclusion that Stxl8-Ml is 
not responsible for the activity seen in the Stxl8-Ml sample. 
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4.5 Concluding Remarks and Future Directions 
At the beginning of this investigation it was taken as a fact that recombinant 
Stxl 8 protein had the ability to cleave c-myc CRD RNA based on the work of Urquhart 
(2006), and indeed it was this assumption that the initial objectives of this thesis were 
based upon (see section 1.5). Regrettably, it was discovered throughout the course of this 
work the conclusion that Stxl8 is an endoribonuclease is probably flawed. It is now 
believed that the activity reported by Urquhart was due to the same as-yet unidentified 
small protein that was implicated in the findings presented in this work. The most likely 
reason for the faulty conclusion presented in Urquhart's work was the fact that all SDS-
PAGE analyses of recombinant protein samples were done on 12% SDS-PAGE gels, 
which only resolve down to a minimum protein molecular weight of 25-30 kDa 
(Urquhart 2006). As such, any small, <10 kDa contaminating proteins, as implicated in 
this work, were never observed. 
Nevertheless, this thesis has succeeded in that it provides evidence against the 
hypothesis that Stxl 8 is an endoribonuclease. This hypothesis was not altogether 
unfounded, as some of the already characterized vertebrate endoribonucleases described 
in section 1.2.2.3 have more cellular functions than solely as an endoribonuclease; 
indeed, the endoribonuclease IRE1 is also an ER-membrane associated protein that 
exhibits protein kinase activity (Zhang et al. 2005) and, more interestingly, sequence 
analysis of the endoribonuclease ARD-1 show that it has sequence similarity to dynamin, 
a protein implicated in endocytosis and membrane trafficking (Claverie-Martin et al. 
1997). 
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Despite the conclusion drawn from this thesis that Stxl8 is not an 
endoribonuclease, future projects could still be carried out using the recombinant 
truncated Stxl8 protein generated for this investigation, albeit with a different focus. As 
mentioned previously, it is not yet known with certainty is Stxl8 can, like its homolog 
Ufelp, for multimers with itself, lending evidence to the hypothesis that Stxl8, again like 
Ufelp, plays a role in eukaryotic homotypic ER membrane fusion. Experiments devised 
in which the ability of recombinant truncated Stxl8 proteins can bind to each other or not 
would lend evidence in support or against this hypothesis. Furthermore, it is also not 
known with certainty whether or not the N-terminal domain of Stxl8 can interact 
internally with its own SNARE domain; to this end, other experiments could be 
performed using recombinant Stxl8-M3 and/or Stxl8-M4 protein in order to determine if 
they can bind to Stxl8-Ml or not. Such structural studies of the Stxl8 protein could 
provide further understanding of the physiological vesicle trafficking role of Stxl8 in 
vertebrate cells. 
As for studies involving the search for novel endoribonucleases, the same 
approach outlined in this work could still be used. The methodology by which an 
endonuclease was discovered leading up to this work (by biochemical purification) was 
an effective way of finding new endoribonucleases, especially considering the fact that 
most known endoribonucleases display no homology to each other, and therefore 
discovery schemes based on conserved sequence and/or structure would not be effective. 
Indeed, the discovery of APE 1 as an endoribonuclease was based on research that 
mimicked the work that lead to this project (Barnes 2007). Unfortunately, it came to 
light partway through this work that the original rat polysomal endoribonuclease sample 
118 
sent for MALDI-MS analysis was improperly prepared for the MALDI-MS process, and 
it could be that this is the reason why Syntaxin 18 was ultimately found not to be an 
endoribonuclease, as the original MALDI-MS tryptic peptide match may have been false. 
If this same method is used in the future in the attempt to discover novel 
endoribonucleases, it would be prudent to duplicate and confirm MALDI-MS data on the 
identity of the protein in question before proceeding with further characterization 
experiments. Furthermore, immuno-depletion experiments using specific monoclonal 
antibody must be performed on both the native and recombinant proteins to confirm their 
RNA-cleaving activities. 
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